IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of California

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

California $ 276,141,790.10
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
3-V BIOSCIENCES INC BROAD SPECTRUM HOST FACTOR DIRECTED ANTIVIRAL THERAPEUTIC $ 244,479.24  
5iSciences, Inc. Application of continous negative external pressure (cNEP) to the upper airway $ 22,834.35 $ 141,124.00
A.P. Pharma, Inc APF530- Prevention of Chemotherapy-induced Nausea and Vomiting $ 244,479.25  
Aaken Laboratories Guided Electrical Stimulation $ 49,026.40 $ 36,267.00
Aardvark Medical, Inc. Nasal Irrigation/Aspiration System $ 244,479.24  
Ablation Numerics Inc Rapid and Simple Cure for Atrial Fibrillation $ 500.00 $ 243,979.25
Acadia Pharmaceuticals Inc. Pimavanserin $ 244,479.25  
Acaduceus Pharmaceutics Inc Developing  Novel Platinum based Targeted-Nanoparticles for Anti-Cancer Drugs $ 12,400.00 $ 132,500.00
Acaduceus Pharmeceutics Inc Developing Targeted Probe for PET imaging of Primary and Metastatic Melanoma $ 56,150.00 $ 180,000.00
Accelalox Inc. Acceleration of Bone Fracture Healing $ 54,062.50 $ 132,430.00
Access Scientific Inc The Wand $ 244,479.25  
Accumetrics, Inc Gravitas: Gauging Responsiveness With a VerifyNow Assay-impact on Thrombosis & Safety $ 244,479.25  
ACEA Biosciences Inc. Development of and cancer treatment with Bis(4-fluorobenzyl)trisulfide (BFBTS) $ 244,479.25  
AcelRx Pharmaceuticals, Inc Sufentanil NanoTab ™ Patient  Controlled Anagesia (PCA) System $ 244,479.25  
AcelRx Pharmaceuticals, Inc. Triazolam/Sufentanil NanoTab ™ $ 244,479.24  
Achaogen, Inc ACHN-490 - A Novel Second-Generation Aminoglycoside Antibiotic for the Treatment of Resistant Bacterial Infections $ 244,479.25  
Achaogen, Inc Novel Expanded-Spectrum Aminoglycosides (ES-AGs) for the Treatment of Pan-Resistant Bacterial Infections Caused by Pseudomonas aeruginosa or Acinetobacter baumannii $ 244,479.25  
Achaogen, Inc Discovery and Development of a Novel Class of Antibacterials, LpxC Inhibitors for the Treatment of Multi-Drug Resistant Bacterial Infections Caused by Gram-Negative Bacteria $ 244,479.25  
Achaogen, Inc. Discovery & Development of a Novel Orally Bioavailable Beta-Lactam for the Treatment of MRSA and Other Multi-Drug resistant Bacterial Infections $ 244,479.24  
Acologix Inc AC 100 $ 88,245.46  
Acologix, Inc. AC820 $ 244,479.25  
Acologix, Inc. AC 200 $ 170,732.65  
Acorn Biomedical Inc T-Fusion ™ Platform for oral Delivery of Recombinant Proteins $ 125,005.10 $ 119,474.15
Acorn Biomedical Inc Development of Adenosine A3 Receptor Antagoinst for the Treatment of Glaucoma. $ 172,773.37 $ 71,705.88
Act Biotech , Inc Telatinib is a new cancer drug that can readily combine with chemotherapy. $ 244,479.25  
ACT Biotech Inc ACTB1003 a novel anti-cancer drug for treatment of cancers with FGFR gene alterations $ 244,479.25  
Active Life Scientific, Inc. Early Diagnosis of Osteoporosis $ 82,273.03 $ 162,206.22
ActiveSite Pharmaceuticals, Inc Preclinical & Early Clinical Development of a NCE Targeting Diabetic Macular Edema $ 136,104.50 $ 108,374.74
A-Cube Inc Bi-specific c-Mat anitbodies to treat abnormal angiogensis in eye disease and cancer $ 244,479.25  
AcuFocus, Inc. ACI 7000PDT $ 244,479.25  
Adamas Pharmaceuticals, Inc. Once-daily Fixed Dose Combination (FDC) for Moderate-Severe Dementia Alzheimer's Type $ 244,479.25  
Adamas Pharmaceuticals, Inc. Triple Combination Antiviral Drug Therapy for the Treatment of Infulenza $ 244,479.25  
Adamas Pharmaceuticals, Inc. Extended-Release Amantadine for Treatment of Levodopa-induced Dyskinesia in Parkinson's $ 244,479.25  
Aduro BioTech Thermotherapy for the treatment of Cancer $ 197,978.50  
Aduro BioTech Listeria-Based Immunotherapy for Cancer and Infectious Disease $ 235,971.50 $ 8,507.75
Advanced Bifurcation Systems Advanced Bifurcation Systems Platform for Complete Bifurcation and Side Branch Stenting $ 150,636.50 $ 93,842.75
Advanced Cell Diagnostics, Inc Diagnostic tests based on in situ RNA detection for personalized cancer management $ 244,479.25  
Advanced Cell Technology Inc Pluripotent Stem Cell Therapy for the Treatment of Stargardt's Macular Dystrophy $ 244,479.25  
Advanced Cell Technology, Inc. Autologous Skeletal Myoblast Transplantation to Treat Ischemic Cardiomyopathy $ 244,479.25  
Advanced Cell Technology, Inc. Generation of Pluripotent Embryonic Stem Cells without Destruction of Donor Embryo $ 244,479.25  
Advanced Cell Technology, Inc. Inducing Pluripotency fron Differentiated Somatic Cells for Autologus Stem Cell Therapy $ 244,479.25  
Advanced Genetic Systems Development of a Novel RNA-protein Complex Inhibitor for Treatment of HIV $ 117,108.50 $ 127,370.75
Advanced Targeting Systems Inc A Novel Cancer Pain Therapeutic $ 19,705.50 $ 21,576.50
Advantageous Systems, LLC ADS-NPTMZ-1, A Novel Nanotherapeutic for Selective Treatment of Advanced Melanoma $ 27,428.00 $ 63,714.00
Adventrx Pharmaceuticals, Inc ANX-530 $ 244,479.25  
ADVENTRX Pharmaceuticals, Inc. ANX-514 $ 244,479.25  
AEGEA Medical Incorporation endometrial ablation $ 244,479.25  
Aeolus Pharmaceuticals, Inc. Development of AEOL11207 as a treatment for Parkinson's disease $ 92,406.00
Aeolus Pharmaceuticals, Inc. Development of AEOL10150 as a treatment for ARS/DEARE $ 244,479.25  
Aespis Biopharmaceutical Company A Novel Cancer Therapeutic   $ 244,479.25
Afferent Pharmaceuticals, Inc Development of a Novel Pharmaceutical, AF-219   $ 244,479.25
Affinity Pharmaceuticals Tumor microenvironment activated prodrug $ 244,479.25  
Affinity Pharmaceuticals PET imaging agents of tumor microenvironment $ 244,479.25  
Affymax, Inc. Peginesatide $ 244,479.25  
Afraxis, Inc Afraxis PAK inhibitor project $ 244,479.24  
Aires Pharmaceuticals Inc Development of Aironite to Treat Pulmonary Arterial Hypertension $ 244,479.24  
Aleeva Medical Inc Alleviate back pain with disc shunt $ 21,732.00 $ 222,747.25
Alexza Pharmaceuticals, Inc. Staccato Loxapine $ 244,479.24  
Alion Pharmaceuticals Inc Development of a new Alzheimer's Therapeutic   $ 167,000.00
Alios BioPharma Inc ALS-2135 Improving Nucleoside Antiviral Properties through a Novel Produg Technology $ 244,479.24  
Alios BioPharma Inc ALS-012117 - A Broad-Spectrum Antiviral that Activates the RNase L Pathway $ 244,479.25  
Alios BioPharma, Inc ALS-2160 - Novel Sugar Substituted Nucleoside for the Treatment of Chronic Hepatitis C $ 244,479.24  
Alios BioPharma, Inc Glycoferon- A Hyperglycosylated interferon with Improved Pharmacokinetitc Properties $ 244,479.24  
Allele Biotechnology & Pharmaceuticals Inc DNA Ratio Change Technology for Prenatal Diagnosis $ 12,458.50 $ 232,020.75
Allele Biotechnology & Pharmaceuticals Inc STEAP4 as a Target for Obesity and Diabetes Therapy $ 17,799.00 $ 24,170.00
Allele Biotechnology & Pharmaceutics, Inc Use of UV-Absorbing Biological products for Skin Protection $ 26,168.50 $ 51,717.00
Allon Therapeutics Inc Davunetide for the treatment of PSP $ 244,479.24  
Allon Therapeutics, Inc. AL-309 for the treatment of peripheral neuropathy $ 137,166.50 $ 107,312.74
Allvivo Vascular, Inc. Dual Function Antimicrobial Catheter $ 142,899.52 $ 101,579.73
ALPHA ORTHOPAEDICS, INC ReleF Technology $ 59,290.00 $ 185,189.24
Alpha Source LLC System for Production of Medical Radioisotopes $ 238,271.21 $ 6,208.03
Altermune Technologies, LLC Altermune: Chemically Programmable Immunity   $ 244,479.24
Altheos Inc. ATS907:  Development of a Novel Topical Rho Kinase Inhibitor for Treatment of Glaucoma $ 10,689.00 $ 233,790.24
Altura Medical, Inc Altlura Medical AAA endograft system to repair abdominal aortic aneurysms $ 244,479.25  
Alvine Pharmaceuticals Inc ALV003 Therapeutic Development Project $ 244,479.24  
Alvine Pharmaceuticals Inc ALV003 2nd Generation Therapeutic Development Project $ 68,374.00 $ 176,105.25
Alvine Pharmaceuticals, Inc Celiac Disease Biomarker development Project $ 23,076.50 $ 143,160.00
Amaranth Medical Inc Coronary Artery Vascular Restoration Therapy Drug Eluting Bioresorbable Stent $ 244,479.24  
Amaranth Medical, Inc Drug Eluting Bioresorable Stent for PVD Vascular Restoration Therapy $ 244,479.24  
Ambit Biosciences Inc AC220 (FLT3) Program $ 244,479.24  
Ambit Biosciences Inc CSF1R/AC710 Kinase Program $ 244,479.24  
Ambit Biosciences Inc AC480 Treatment Program $ 244,479.24  
AMBIT BIOSCIENCES, INC. AC430 JAK2 KINASE PROGRAM $ 244,479.24  
Ambrx Inc PEG-Leptin for the treatment of obesity and Type 1 Diabetes $ 244,479.25  
Ambrx Inc ARX-Trail for the treatment of metastatic colon cancer $ 217,366.50 $ 27,112.75
AMBRX, INC ANTIHER2-DOLOSTAIN ANTIBODY ("ARX-AHD) for the treatment of breast cancer $ 244,479.25  
Ambrx, Inc Anti-VEGF-Anti-Ang2 for the treatment of newvascular age related macular degeneration $ 244,479.25  
AMBRX, INC ARX618(FGF21) for the treatment Type II Diabetes $ 244,479.25  
American Life Science Pharmaceuticals, Inc. Alzheimer's Disease Cathepsin-B Inhibitor Therapeutics $ 244,479.24  
AMIRA PHARMACEUTICALS, INC Lysophospahidic Acid Receptor Antagonist and Inhibitor (LPA) $ 244,479.25  
AMIRA PHARMACEUTICALS, INC PROSTAGLANDIN D2 RECEPTOR ANTAGONIST (DP2) $ 244,479.25  
Amplyx Pharmaceuticals Inc A Hybrid Therapeutic with superior Efficacy Against Resistant Infections   $ 54,626.50
Amplyx Pharmaceuticals, Inc Novel Taxane with Greatly Reduced Peripheral Neuropathy for Cancer Therapy   $ 96,445.50
Amplyx Pharmaceuticals, Inc A Novel Carbapenem Antibiotic to improve Therapeutic Outcomes $ 81,777.50 $ 83,514.50
Amplyx Pharmaceuticals,Inc Novel, Targeted HIV Protease Inhibitor to Improve Therapeutic Outcomes $ 149,473.50 $ 71,016.50
Amunix, Inc CANCER   $ 139,116.83
Amunix, Inc Genetic Deficiency   $ 69,238.29
Amunix, Inc Immune Diseases   $ 172,881.67
Anacor Pharmaceuticals, Inc AN2898, a topical anti-inflammatory therapy for the treatment of atopic dermatitis $ 244,479.25  
Anacor Pharmaceuticals, Inc AN5973, a novel agent for treatment of Enterobacteriaceae infections caused by Enterobacteriaceai bacteria. $ 244,479.25  
Anacor Pharmaceuticals, Inc Novel agents to treat Community-Acquired Respiratory Tract Infections. Novel boron-containing small molecule antibacteria agents to treat community-acquired respiratory tract infections (CART1) $ 244,479.25  
Anacor Pharmaceuticals, Inc AN2728, a novel topical anti-inflammatory therapy for psoriasis $ 244,479.25  
Anacor Pharmaceuticals, Inc AN2690, a novel, broad spectrum antifungal therapy for onychomycosis $ 136,082.50 $ 108,396.75
Anacor Pharmaceuticals, Inc. AN2718, a topical antifungal therapy for tinea pedis $ 244,479.25  
Anadys Pharmaceuticals Inc ANA598 $ 244,479.25  
Anadys Pharmaceuticals Inc ANA773 $ 244,479.25  
Anaphore, Inc. TL1A-Atrimer Therapeutic $ 206,740.50 $ 37,738.75
Anaphore, Inc. TRAIL-R-Atrimer Therapeutic $ 244,479.25  
Anaphore, Inc. IL-23R/IL-10R-Atrimer Therapeutic $ 244,479.25  
AnaptysBio Inc A Novel Therapeutic Antibody for the Treatment of Chronic Autoimmune Disease (ANA04) $ 244,479.25  
AnaptysBio Inc A Novel Therapeutic Antibody for the Treatment of Bone Loss (ANA01). $ 237,033.00  
AnaptysBio Inc A Novel Therapeutic Antibody for the Treatment of Chronic Pain (ANA01) $ 244,479.25  
AnaptysBio Inc A Novel Therapeutic Antibody for the Treatment of Complement Mediated Diseases (ANA06) $ 48,992.00 $ 85,498.50
AndroScience Corporation A New Class of Anti-Androgen Targeting Androgen Receptor (AR) $ 244,479.25  
Angelica Therapeutics Inc Nonimmunogenic Fusion Toxin Platform for Cancer Therapy $ 244,479.25  
Angstrom Pharmaceuticals, Inc A6 a Novel CD44 Targeting Cancer Therapeutic $ 244,479.25  
ANTHERA PHARMACEUTICALS INC A-001 $ 244,479.25  
Anthera Pharmaceuticals Inc A-623 for Rheumatoid Athritis $ 10,966.00 $ 233,513.25
Anthera Pharmaceuticals, Inc A-002 $ 244,479.25  
ANTHERA PHARMACEUTICALS, INC. A-623 $ 10,966.00 $ 233,513.25
AntiCancer, Inc. Targeted Tumor-Killing Bacteria $ 87,322.16 $ 83,804.41
Apama Medical Inc RF Project $ 101,461.50 $ 143,017.75
Applied BioCode Inc Barcoded Magnetic Beads (BMB) for Molecular Diagnostics $ 244,479.25  
Applied Biotechnology Institute, Inc. An Orally Delivered Hepatitis B Vaccine $ 123,187.50 $ 115,568.50
APT Pharmaceuticals, Inc. Cyclosporine Inhalation Solution to prevent and treat rejection following lung transplant $ 244,479.25  
Aptus Endosystems, Inc The Aptus Endostape in the prevention and treatment of abominal aortic aneurysms $ 244,479.25  
AqueSys Inc Aquesys Microfistula Implant $ 244,479.25  
Ara Medical, LLC Sprayable biodegradeable polymers as adhesion barriers & drug delivery modality $ 183,828.00 $ 60,651.25
Aradigm Corporation ARD-3100-Liposomal Ciprofloxacin for the treatment of Cystic Fibrosis $ 244,479.25  
ARADIGM CORPORATION ARD-3100 -- Liposomal Ciprofloxacin for the Treatment of Non-Cf Bronchiectasis $ 244,479.25  
ARADIGM CORPORATION ARD-3150-Liposomal Ciprofloxacin for the Treatment of Non-CF Bronchiectasis $ 244,479.25  
Aragon Pharmaceuticals, Inc 3rd Generation Anti-Androgens $ 244,479.25  
Aragon Pharmaceuticals, Inc ARN-509 $ 244,479.25  
Aragon Pharmaceuticals, Inc. SERD $ 244,479.25  
Aravasc Inc Multi-modal drug delivery system for local delivery of Cancer Chemotherapy $ 135,274.28 $ 109,204.97
Arbor Vita Corporation NA-1 $ 244,479.25  
Arbor Vita Corporation AVC Avantage HPV E6 Test $ 244,479.25  
Arbor Vita Corporation Anvantage A/H5N1 Flu Test $ 244,479.25  
Ardea Biosciences Inc Next-generation URAT1 Therapeutic Discovery Project $ 244,479.25  
Ardea Biosciences Inc RDEA119-MEK Inhibitor Therapeutic Discovery Project $ 244,479.25  
Ardea Biosciences Inc RDEA594-URAT1 Therapeutics Discovery Project $ 244,479.25  
Ardelys Inc. RDX5791 for the treatment of CIC, IBS-C predominant and OBD $ 244,479.25  
Ardelyx Inc. RDX002 for the treatment of elevated phosphorus in chronic kidney disease $ 244,479.25  
Ardelyx, Inc RDX008 treatment of salt and fluid overload in heart failure, CKD and hypertension patients congestive heart failure (CHF), chronic kidney disease and hypertension. $ 119,704.00 $ 124,775.25
Argusina, Inc. Novel Small Molecular Modulator of GLP1 Receptor for Anti-Diabetes/Obesity Treatment $ 171,732.44 $ 72,746.80
Aridis Pharmaceuticals LLC Aridis Formulation Technology Program $ 244,479.25  
Aridis Pharmaceuticals, LLC Aridis Novel Anti-Infective Therapies Program $ 244,479.25  
ArKal Medical Inc ArKal Continuous Glucose Monitor $ 244,479.24  
ArmaGen Technologies Inc Drug Development of Brain-Penetrating Biopharmaceuticals $ 244,479.24  
Arresto Biosciences, Inc AB0024, a Novel Inhibitor of LOXL2 for the Treatment of Cancer and Fibrotic Diseases $ 244,479.25  
Arrowhead Research Corporation Rondel $ 244,479.25  
Arstasis, Inc. ArtasisONE Vascular Access System $ 244,479.25  
Artemis Health, Inc. Noninvasive Prenatal Diagnosis of Down Syndrome Using Next-Generation DNA Sequencing $ 244,479.25  
Artery Therapeutic, Inc Artery Therapeutic, Inc: Diagnostic Program $ 41,602.96 $ 202,876.29
Artery Therapeutics, Inc Artery Therapeutic, Inc: Therapeutic Program $ 172,743.80 $ 71,735.45
Aryx Therapeutics Inc Tecarfarin Novel Oral Anticoagulant Therapeutic $ 244,479.24  
Aryx Therapeutics Inc ATI-7505 for the treatment of gastrointestinal motility dysfunctions $ 148,714.50 $ 95,764.74
ARYX THERAPEUTICS INC Budiodarone oral therapeutic for the tratment of atrial fibrillation $ 244,479.24  
ARYX THERAPEUTICS, INC. ATI-9242 for the treatment of schizophrenia and depression $ 111,106.50 $ 99,439.50
Asante Solutions, Inc. Personal Infusion System $ 244,479.24  
Asthmatx, Inc. TREATING CHRONIC RESPIRATORY DISEASES WITH ALAIR SYSTEM $ 244,479.25  
ASTRAEA THERAPEUTICS, LLC POLYDRUG ADDICTION TREATMENT $ 4,682.50 $ 93,112.00
Astraea Therapeutics, LLC Novel Therapies for Parkinsons Disease and Dyskinesia   $ 38,713.50
Astute Medical, Inc A Novel Biomaker Panel for the Early Detection of Acute Kidney Injury $ 244,479.24  
AtheroMed, Inc. Phoenix Atherectomy System $ 244,479.25  
aTyr Pharma Inc. Tmax, an Innovative Biological Therapy for Thrombocytopenia $ 244,479.24  
aTyr Pharma Inc. ATYR1920, a novel immunomodulatory agent for IBD $ 244,479.24  
Auritec  Pharmaceuticals Sustained Release Apomorphine for  the Treatment of Parkinson's Disease $ 80,827.37 $ 46,125.17
Auritec Pharmaceuticals Intravaginal ring releasing acyclovir for the prevention of HSV transmission $ 105,580.61 $ 92,197.62
Auritec Pharmaceuticals Sustained Release Cyclosporine for the Prevention of Graft Rejection $ 51,081.86 $ 193,397.39
Auritec Pharmaceuticals Sustained Release Nevirapine for the Treatment of HIV $ 65,989.98 $ 14,366.85
Auritec Pharmaceuticals Sustained Release Olanzapine for the Treatment of Schizophrenia and Mania   $ 68,881.55
Auspex Pharmaceuticals, Inc. SD-560-Deuterated pirfenidone analog for treatment of idiopathic pulmonary fibrosis $ 239,933.37 $ 4,545.88
Automedics Medical Systems, Inc. HepGuide Decision Support Software $ 157,334.50 $ 87,144.74
Autonomic Technologies Inc Delivery of Therapeutics for Migraine and Cluster Headache $ 244,479.25  
Avanir Pharmaceuticals, Inc Zenvia $ 244,479.25  
Avantis Medical Systems Development and Clinical Trials of the Third Eye Retroscope, a Device to Enhance Detection and Treatment of Colonic Adenomas and Prevent Colorectal Cancer $ 244,479.25  
AvidBiotics Corp R-Type Pyocins as Novel Antibacterials $ 244,479.24  
AvidBiotics Corp Targeted MICA Molecules to Recruit Innate Immunity Cells to Kill Specific Viruses $ 38,082.50 $ 82,718.00
Aviir, Inc. Aviir Blood Test for Heart Disease $ 244,479.24  
Axikin Pharmaceuticals, Inc. Axikin Pharmaceuticals:  Novel Small Molecule Therapy for Asthma $ 244,479.25  
Azee Inc. Development of a new class of antibacterial and antiviral drugs using SMAT technology $ 27,619.85 $ 77,000.00
Balance Therapeutics, Inc Developing the first potential drug to treat the cognitive impairment in Down Syndrome $ 14,389.84 $ 230,089.41
BARnova, Inc TransPyloric Shuttle $ 244,479.24  
BaroSense Inc Trans-oral Endoscopic Restrictive Implant System (TERIS) $ 244,479.24  
BARRX MEDICAL INC. Albation of Squamous Neoplasia and Esophegeal Squamous Cell Carcinoma $ 43,364.00 $ 69,826.00
BARRX MEDICAL INC. Albation of Intestinal Metaplasia (AIM) Dysplasia Extension of follow-up to 5 years $ 218,622.50 $ 25,856.75
BARRX MEDICAL INC. Halo Patient Registry- Ablation of Barrett's Esophagus $ 244,479.25  
BARRX MEDICAL INC. Micro-Layer Ablation of Barrett's Metaplasia- Extension of Follow-Up to 5 years $ 52,077.00  
Bayhill Therapeutics BHT - 3021 $ 244,479.25  
Bayhill Therapeutics BHT - 3034 $ 244,479.25  
Bebaas Inc Cyprem $ 242,500.00 $ 1,979.25
Bebaas Inc Cobacan $ 242,500.00 $ 1,979.25
BeneChill, Inc RhinoChill $ 244,479.24  
Beyond Lucid Technologies, Incorporated MEDIVIEW DX by Beyond Lucid Technologies, Inc. $ 9,477.83 $ 157,022.86
BFIONOVO, Inc. MENERBA $ 244,479.25  
Bio Time Inc Induced Pluripotent Stem Cell Technologies $ 112,580.75 $ 131,898.50
Bio3 Research Inc. HMGB1 for accelerated wound healing $ 20,439.00 $ 32,032.00
BioAssay Systems LLC Development of Pharmacodynamic and Diagnostic Assays for Cancer Drug Targets $ 244,479.24  
BioAtla, LLC Development of a High Affinity Antibody for nonHodgkin's Lymphomas $ 28,500.00 $ 37,350.00
BioCardia, Inc Helical Infusion System for Heart Failure $ 244,479.25  
Biocept, Inc. CEE Cell Enrichment and Extraction Platform Technology $ 244,479.25  
Biodesy LLC Discovery of a highly specific and potent therapeutic for Parkinson's disease $ 71,058.50 $ 39,996.50
BioDx Partners LLC Development and Commercialization of a Blood Test for Non-Small Cell Lung Cancer $ 3,450.50 $ 138,599.50
Bioenergenix, LLC BioEnergenix $ 244,479.25  
BioGenex Laboratories Develop fully automated tools for quantitative gene expression profiling in situ for cancer. $ 244,479.25  
Biological Dynamics, Inc. Point of Care Cancer Diagnostic Device   $ 244,479.25
Biomatrica Inc Development of Molecular Diagnostic Tools for High-Sensitivity Cancer Detection $ 244,479.25  
BioMedicure LLC Developing Cancer Vaccines to Prevent and Treat Cancer including Melanoma $ 196,047.50 $ 48,431.74
Biomerica Inc Enzyme-Linked Immunosorbent Assays (ELISA) $ 172,890.28 $ 71,588.97
Biomerica, Inc Microalbumin Project $ 44,185.60 $ 68,811.41
BIONOVO, INC BEZIELLE $ 244,479.25  
BioTechPlex Corporation SUPRAER:High Dose-Rate Aerosol Delivery of Biotherapeutics $ 19,271.00 $ 36,681.50
BioTime Inc ACTCellerate Embryonic Progenitor Cells $ 244,479.25  
BioTime, Inc Chondrocyte Progenitor Cells $ 119,663.74 $ 124,815.51
BioVascular Inc Anagrelide Control Release for Cardiovascular Risk Reduction $ 244,479.24  
BioVascular Inc. Development of Saratin to increase vascular graft survival $ 244,479.24  
Bioxiness Pharmaceuticals Development of Novel and New Class of Antimicrobial Therapeutics $ 18,780.00 $ 225,699.25
BN Immuno Therapeutics Inc MVA-BN-HER2 $ 244,479.25  
BN Immuno Therapeutics Inc PROSTVAC $ 244,479.25  
BrainCells Inc BCI-632 $ 244,479.25  
BrainCells Inc. BCI-540 $ 244,479.25  
BrainCells Inc. BCI-952 $ 244,479.25  
BrainCells Inc. BCI-224 $ 244,479.25  
Broncus Technologies, Inc LungPoint Planning and Navigation Systems $ 244,479.25  
Broncus Technologies, Inc. Airway Bypass with Drug-Eluting Stents $ 244,479.25  
Broncus Technologies, Inc. FleXNeedle Tissue Sampler (18 Gauge) $ 244,479.24  
Bruin Biometrics, LLC Sub-epidermal moisture scanning device $ 244,479.25  
C2 Therapeutics, Inc Cryoballon Ablation System for Barrett's Esophagus $ 176,887.51 $ 67,591.74
C3 Jian, Inc. Specifically-targeted  antimicrobial peptides ("STAMPs) $ 244,479.25  
C8 MediSensors, Inc. HG-1c Noninvasive Glucose Monitor $ 244,479.25  
Cadence Pharmaceuticals, Inc. OFIRMEV, A NEW INTRAVENOUS TREATMENT FOR ACUTE PAIN AND FEVER $ 244,479.25  
Caerus Molecular Diagnostics Inc. Low-Cost Diagnostic Platform using Millikan Sequencing   $ 150,000.00
CalciMedica, Inc Novel therapies for autoimmune diseases $ 244,479.24  
Caldera Medical, Inc POP SI $ 117,025.76 $ 127,453.49
Caldera Medical, Inc. Desara Mini $ 140,691.80 $ 103,787.44
Calibra Medical, Inc. Finesse Personal Insulin Delivery System $ 244,479.24  
Califia Bio, Inc. Discovery of Novel Therapeutics for the Treatment of HIV-associated Neurological Disease $ 128,113.00 $ 116,366.25
California Stem Cell Inc MotorGraft $ 244,479.25  
Calithera Biosciences Inc Caspase Activator Program   $ 244,479.25
Cameron Health, Inc S-ICD System, Subcutaneous Implantable Defibrillator to Treat Sudden Cardia Death $ 244,479.25  
Cantimer Incorporated Osmo Point-of-Care Dehydration Diagnostic System $ 244,479.25  
Capnia, Inc. A Novel Therapeutic Product for Treating Migraine $ 244,479.24  
Capnia, Inc. A Novel Therapeutic Product for Allergic Rhinitis $ 244,479.24  
Capnia, Inc. A Novel Diagnostic Device for Detecting Hemolysis $ 3,915.00 $ 240,564.24
Capricor, Inc. Cardiosphere-derived stem cell therapy for advanced heart failure $ 129,094.00 $ 115,385.25
Capso Vision Inc CapsoCam Colon Capsule Endoscope $ 244,479.25  
Carbylan Biosurgery Inc. Hydros TA $ 244,479.25  
Cardero Therapeutics, Inc Mitochondrial Protection and Stimulation (MIPS) Drug Development Program $ 95,437.50 $ 149,041.75
Cardigant Medical Inc Project Nautilus $ 60,200.00 $ 110,550.00
Cardima, Inc. Catheter ablation technology $ 244,479.24  
CARDIODX INC Corus SCA (sudden cardiac arrest)genetic test for the detection of cardiac arrhythmia risk $ 244,479.24  
CardioDx, Inc. Corus CAD gene expression test for obstructive coronary disease (CAD) $ 244,479.24  
Cardiogenesis Corporation and Subsidiaries Phoenix Project $ 195,528.76 $ 48,950.49
Cardiovascular Simulation Inc CT Flow:  Non-Invasive Assessment of Coronary Artery Disease $ 119,606.00 $ 124,873.25
Cardium Therapeutics, Inc. Generx ®  ("Generx") $ 244,479.24  
Carmot Therapeutics, Inc Identification of novel anticancer drugs   $ 244,479.24
Carolus Therapeutics, Inc Peptide Therapeutic-CT-2008 $ 244,479.25  
Catalyst Biosciences, Inc. Improved recombinant human Factor Vlla $ 244,479.24  
Catalyst Biosciences, Inc. Anti-complement Alterase TM therapeutic program $ 244,479.24  
Catalyst Biosciences, Inc. Improved recombinant human Factor IX $ 244,479.24  
CEBIX Incorporated C-Peptide Replacement Therapy $ 244,479.24  
Cell Biosciences, Inc Nanoimmunoassay for Biomarker Detection $ 244,479.24  
Cell Viable Corp Small Molecule to treat Neurodegenerative Disease such as Alzheimers   $ 17,250.00
Celladon Corporation MYDICAR (AAV1/SERCA2a) for treatment of NYHA Class III/IV symptoms of heart failure $ 244,479.24  
CellScape Corporation CellScape NIPD System $ 244,479.24  
CellSight Technologies Inc Imaging cell trafficking to advance clinical translation of cell and gene therapeutics   $ 105,795.00
Celprogen Inc. Therapeutic agents for the treatment of Breast Cancer triple negative patients $ 107,500.00 $ 136,979.24
Celula Inc High-Capacity Single-Cell Molecular Diagnostics for Non-Invasive Prenatal Genetic Testing $ 244,479.25  
Cenna Biosciences Inc Peptide Drugs to Treat Alzheimer's Disease $ 16,248.50 $ 228,230.75
Ceregene, Inc Ceregene, Inc $ 244,479.25  
Ceregene, Inc Neurotrophic Factor Therapy (AAV-NGF) for the Treatment of Alzheimer's Disease (CERE-110) $ 244,479.25  
Ceregene, Inc. Delivery of NT-4 for the Treatment of Degenerative Ocular Diseases (CERE-140) $ 244,479.25  
Cerimon Pharmaceuticals Diclofenac sodium topical patch for treatment of acute musculoskeletal pain $ 244,479.24  
Cerus Corporation INTERCEPT Pathoogen Inactivation for Platelets $ 244,479.25  
Cerus Corporation INTERCEPT Pathogen Inactivation for Red Blood Cells $ 244,479.25  
Charisela Technologies Inc Charisela Technologies:  Advanced Reagent Technologies   $ 213,581.03
CHEM DIV INC NOVEL SMALL MOLECULE HEDGEHOG PATHWAY INHIBITORS AS ANTICANCER AGENTS $ 73,690.00 $ 65,481.00
ChemGenex Pharmaceuticals, Inc. Omacetaxine Mepesuccinate $ 244,479.24  
ChemoCentryx Inc Treating Chronic Hepatitis with C0334578 $ 244,479.25  
ChemoCentryx, Inc Treating Glioblastoma Cancers with CCX662 $ 244,479.24  
ChemoCentryx, Inc Treating Vasculitis with CCX168 $ 244,479.24  
ChemoCentryx, Inc Treating Rheumatoid Arthritis with CCX354 $ 244,479.24  
ChemoCentryx, Inc. Treating Inflammatory Bowel Disease (IBD) with CCX282 $ 244,479.25  
ChemoCentryx, Inc. Treating Type 2 Diabetes with CCX140 $ 244,479.24  
ChemoCentryx, Inc. Treating Atopic Dermatitis with C0333158 $ 125,808.00 $ 118,671.25
ChemoCentryx, Inc. Treating Inflammatory Bowel Disease (IBD) with CCx025 $ 244,479.24  
ChemRegen, Inc. New Stem Cell Therapies for Heart Disease   $ 244,479.25
CHF Technologies Inc PliCath HF System $ 244,479.24  
ChromoLogic LLC Occular Radiation Dosimeter (OCDOS)   $ 244,479.25
ChromoLogic LLC Rapid brain injury dosimeter (RAPIDOS)   $ 29,394.00
ChromoLogic LLC Amplified Refractometric interference Analysis System $ 48,256.00 $ 20,344.00
ChromoLogic LLC Debridement and Vitality Assessment System (DAVANIS) $ 6,429.00 $ 29,587.00
ChromoLogic LLC Reactie Chest Seal (ReSEAL) $ 7,842.00 $ 14,863.50
ChromoLogic LLC Fluid preservation system (FPS)   $ 28,191.00
ChromoLogic LLC Label free integrated biofilm analysis (LIBA) system $ 16,109.00 $ 16,385.00
ChromoLogic, LLC Occular Hydration Monitor (OCHYMO) $ 110,770.50 $ 120,380.00
Chronix Biomedical, Inc. Apoptosis Blood DNA Test to Guide Therapeutic Decisions in Cancer Management $ 244,479.25  
Cianna Medical, Inc SAVI Applicator System $ 244,479.25  
Claremont Biosolutions LLC Rapid Sample Preparation and Detection of C. diff. and Other Pathogens $ 234,671.10 $ 9,808.15
Claret Medical, Inc Dual Filter Embolic Stroke Prevention Catheter $ 77,166.00 $ 154,500.00
Clarity Medical Systems, Inc Holos, a unique, high resolution, real time optical measurement technology for opthalmology $ 192,231.50 $ 52,247.75
Clarity Medical Systems, Inc Advanced Next Generation System for Diagnostic Ocular Imaging $ 244,479.25  
Clincial Micro Sensors, Inc K-ras mulation cancer treatment $ 8,188.50 $ 236,290.75
Clinical Micro Sensors Inc AD-8 DNA System $ 171,256.00 $ 73,223.25
Clinical Micro Sensors, Inc Plavix Sensitivity Drug $ 60,588.00 $ 183,891.25
Clinical Micro Sensors, Inc Warfarin Sensitivity Test $ 110,390.50 $ 68,026.00
Clinical Micro Sensors, Inc. Thrombophilia Risk Test (TRT) $ 244,479.25  
Clinical Micro Sensors, Inc. Respiratory Viral Panel (RVP) $ 244,479.25  
Clinical Micro Sensors, Inc. Cystic Fibrosis Genotyping (CF) $ 244,479.25  
CoaguSense, Inc CoaguSense Coagulometer Project $ 244,479.25  
CoaguSense, Inc. Hemophilia Therapeutic Monitoring Project   $ 220,220.50
Coda Therapeutics, Inc Nexagon ® For the Treatment of Venous Leg Ulcers $ 244,479.25  
Colby Pharmaceutical Company Development of a New Chemical Entity Inhibiting JunD Activation of the Androgen Receptor   $ 244,479.25
Colby Pharmaceutical Company Clinical Development of CPC-100 for Recurrent Prostrate Cancer $ 51,500.00 $ 192,979.25
Colby Pharmaceutical Company Androgen Receptor DNA Vaccine for Prostate Cancer Patient in Vivo Immunization   $ 244,479.25
Colby Pharmaceutical Company Tempol-based Radioprotective Solid State Oral Drug Formation for US stockpile   $ 244,479.25
COMBIMATRIX CORPORATION COMPREHENSIVE CANCER ARRAY, OR "CCA" $ 244,479.24  
Combimatrix Molecular Diagnostics, Inc Array Comparative Genomic Hybridization, or "aCGH" $ 244,479.24  
CoMentis Inc BACEi $ 244,479.25  
Complete Genomics, Inc. Complete Human Genome Sequencing for Personal Medicine $ 244,479.24  
CONATUS PHARMACEUTICALS INC. CTS-1027 $ 244,479.24  
CONCENTRIC MEDICAL, INC The Trevo system provides rapid clot integration and removal in patients experiencing acute ischemic stroke. $ 244,479.25  
Conkwest Inc. NK-92 $ 17,594.05 $ 179,775.00
Corcept Therapeutics Incorporated Selective GR-II Antagonist-CORT 108297- Treatment of Antipsychotic Induced Weight Gain $ 244,479.25  
Corcept Therapeutics Incorporated CORLUX for Treatment of Endogenous Cushing's Syndrome $ 244,479.25  
Corcept Therapeutics, Incorporated CORLUX for the treatment of Psychotic Depression $ 244,479.25  
Corium International Inc MicroCor PTH(1-34) transdermal delivery system for osteoporosis $ 244,479.25  
Cortene Inc Hercules   $ 244,479.24
Cortex Pharmaceuticals Inc CX1739 A novel Ampakine Molecule for Neurologicial and Psychiatric Disorders $ 244,479.24  
Crescendo Bioscience, Inc Vectra ™ DA (Disease Activity Test) $ 244,479.25  
Crescendo Bioscience, Inc. Crescendo Structural Damage Test $ 244,479.25  
CRISI Medical Systems, Inc Advanced Cardiac Life Support (ACLS) Drug Delivery System $ 1,938.05 $ 242,541.20
Cura Medical Technologies LLC Range Compensator and Aperture Development for Proton Beam Radiation Therapy   $ 244,479.24
CuraSeal Inc PICS therapeutics delivery system $ 244,479.24  
Customized Therapeutics LLC Biomarker for prediciting response to chemotherapy in prostate cance patients $ 31,666.67 $ 60,000.00
Customized Therapeutis LLc Biomarker for predicting respons to chemotherapy in breast cancer patients $ 36,666.67 $ 105,000.00
Cylene Pharmaceuticals Inc CX-7000 next generation CK2 inhibtor as a personalized anticancer agent with accompanying diagnostic kit $ 244,479.24  
Cylene Pharmaceuticals Inc FiRST-IN-CLASS CX-6258 PAN-PIM KINASE INHIBITOR AS A PERSONALIZED ANTICANCER AGENT WITH ACCOMPANYING DIAGNOSTIC KIT $ 244,479.24  
CYLENE PHARMACEUTICALS, INC FIRST-IN-CLASS RNA POLYMERASE I INHIBITORS AS PERSONALIZED ANTICANCER AGENTS $ 244,479.24  
Cylene Pharmaceuticals, Inc FIRST-IN-CLASS CX-4945  INHIBITORS AS PERSONALIZED ANTICANCER AGENTS with accompanying diagnostic kit $ 244,479.24  
Cynvenio Biosystems, Inc. Liquid Biopsy:  Oncogenetic analysis of Cancerous Circulating Tumor Cells $ 229,743.50 $ 14,735.74
CytoDesign Inc (CDI) Homogeneous Assay Platform for Clinical Diagnostics $ 23,288.00  
CytoDesign, Inc (CDI) Engineering Proteolytic Therapeutics for Biodefense $ 45,637.50  
CytoDesign, Inc. (CDI) Engineering Proteolytic Therapeutics for Psoriasis $ 80,099.00 $ 78,151.50
Cytokinetics, Inc Cardiac Muscle Activators for Heart Failure $ 244,479.24  
Cytokinetics, Inc Skeletal Muscle Activators $ 244,479.24  
Cytokinetics, Incorporated Smooth Muscle Myosin Inhibitors $ 244,479.24  
CytomX Therapeutics, LLC Armed Probodies for the Treatment of Colon and Head & Neck Cancer and GBM $ 175,983.50 $ 68,495.74
CytomX Therapeutics, LLC Probodies for the Treatment of Triple Negative Breast Cancer and Pancreatic Cancer $ 171,354.00 $ 73,125.24
Cytori Therapeutics Inc The Celution System for the delivery of adipose derived stem and regenerative cells $ 244,479.25  
CytoScale Diagnostics , LLC New-Generation CTC Cancer Diagnostic Devices   $ 244,479.24
Cytotech Labs LLC Cytotech Labs, Api 31510 $ 244,479.24  
CytRx Corporation INNO-206 a prodrug of doxorubicin, which selectively becomes active in tumors. $ 244,479.25  
CytRx Corporation Tamibarotene, a novel retinoid drug for treatment of a rare form of leukemia $ 244,479.25  
CytRx Corporation Clinical trials with Bafetinib $ 146,172.50 $ 98,306.75
DataPhysics Research, Inc CaseReader: Healthcare Image Processing System $ 173,150.00 $ 71,329.24
Dean Allgeyer, M.D Simplified Vital Signs Acquisition for the Medical Home $ 3,252.50 $ 5,397.50
Depomed, Inc DM-1992 for the Treatment of Parkinson's Disease $ 244,479.24  
Depomed, Inc Serada for the Treatment of Menopausal Hot Flashes $ 244,479.25  
DermTech International Epidermal Genetic Information Retrieval $ 244,479.24  
Deton Corp Cough analyzer of airborne bacteria for tuberculosis and pulmonary disease diagnosis   $ 66,463.50
Devax, Inc Axxess Drug Eluting Bifurcation Stent $ 244,479.24  
Dfine, Inc StabiliT therapeutic delivery system $ 244,479.24  
DNAmicroarray, Inc. Chemically Induced Reprogrammed Human Somatic Stem Cells for Treatment of Human Medi $ 244,479.25  
DOSE Medical Corporation DOSE Medical Drug Delivery Platform   $ 244,479.24
Duke Vascular,In. Taheri LaDuca Endograft $ 161,302.23 $ 83,177.02
Durect Corporation ORADUR $ 244,479.25  
DURECT CORPORATION POSIDUR PROGRAM $ 244,479.25  
DURECT CORPORATION BIOBETTERS PROGRAM $ 244,479.25  
DxTerity Diagnostics Incorporated Rapid Point of Care Genetic Testing Platform for Complex Gene Expression Assays $ 177,025.00 $ 67,454.24
Dynavax Technologies Corporation HEPLISAV, Hepatitis B Vaccine $ 244,479.25  
Dynavax Technologies Corporation DV1179 for the Treatment of Systemic Lupus Erythematosis $ 244,479.25  
Dynavax Technologies Corporation Universal Flu Vaccine N8295/llVSA $ 244,479.25  
Edison Pharmaceuticals, Inc. EPI-743 $ 244,479.25  
Edison Pharmaceuticals, Inc. CNTO-530   $ 244,479.25
Eiger Biopharmaceuticals, Inc EBP921 $ 138,813.50 $ 105,665.75
EIGER BIOPHARMACEUTICALS, INC CLEMIZOLE AND BACK UPS $ 244,479.25  
Elcelyx Therapeutics Inc Targeting Gut Chemosensory Receptors to Treat Obesity and Diabetes $ 62,465.50 $ 182,013.75
Elevation Pharmaceuticals, Inc EP-101(LAMA) $ 244,479.24  
Elixir Medical Corporation Drug Eluting Stent (DES) $ 244,479.25  
Elixir Medical Corporation Fully Bioresorbable Drug Eluting Stent (BDES) $ 244,479.25  
ELIXIR MEDICAL CORPORATION Oncology Platforms $ 199,084.50 $ 45,394.75
Elixir Medical Corporation Ophthalmis Drug Eluting Implants $ 199,094.00 $ 45,385.25
Elixir Medical Corporation Drug Eluting Stent (DES) with Bioabsorbable Coating (DESyneBD) $ 244,479.25  
Ellipse Technologies Inc Ellipse MAGEC Technology $ 244,479.24  
Emiliem, Inc Translational Development of a Novel mTOR Pathway inhibitor for Unmet Medical Needs   $ 244,479.25
EMKinetics Inc. An Electromagnetic neurostimulator for treatment of overactive bladder (OAB) $ 244,479.25  
EndogenX Inc. Endothelin Antagonist in Non-Opiate Analgesia $ 52,778.00 $ 191,701.25
ENDOLOGIX, INC. PEVAR $ 58,092.00 $ 186,387.25
Endoscopic Technologies, Inc DBA Estech Treatment of Atrial Fibrillation Utilizing Temperature Controlled Radio Frequency Surgery $ 244,479.24  
EndoSphere Inc. SatiSphere Duodenal Insert $ 221,690.50 $ 22,788.75
EnGen Bio, Inc. Recombinant Human Albumin from an Optimized Expression Sstem   $ 244,479.24
Entelos Inc Hematopiesis Compound Evaluation $ 88,712.50  
Entelos, Inc Rheumatoid Arthritis Inflammatory Evaluation Project $ 65,750.00 $ 27,387.50
Entelos, Inc Rheumatoid Arthritis Inflammatory Targets Evaluatuion $ 58,118.00  
EntroGen Inc development of a diagnostic test to aid in therapeutic decisions for colorectal cancer patients $ 244,479.24  
ENVY MEDICAL INC Novel oligopeptides for the treatment and prevention of melanoma $ 68,250.00 $ 139,190.00
Eos Neuroscience Inc. Development of EOS-013, a Therapy to Restore Vision to Blind RP and AMD Patients $ 53,377.13 $ 191,102.12
EPEIUS BIOTECHNOLOGIES CORPORATION REXIN-G, TARGETED MOLECULAR GENE THERAPY FOR CANCER $ 244,479.25  
Epic Sciences, Inc. CTC-HRP, predicting the response to anti-hormone receptor drugs in cancer patients $ 226,377.50 $ 18,101.75
Epicardial Technologies Inc. Epicardial Treatment and Diagnosis of Cardiac Arrhythmias   $ 244,479.24
Epicenter Software Biologist Oriented Workbench for Genomic Integration. $ 108,042.00 $ 108,500.00
Epigen Biosciences Inc. Discovery and development of novel agents for the treatment of pruritis   $ 716.40
Epigen Biosciences, Inc. Discovery and development of novel agents for the treatment of renal fibrosis   $ 3,023.16
Epinex Diagnostics, Inc G1A Rapid Diabetes Monitoring Index Test $ 244,479.24  
Epiphany Biosciences, Inc. Phase 2 Clinical Development of Valomaciclovir $ 244,479.25  
EPITOGENESIS INC VACCINE FORMULATION   $ 244,479.25
Epitomics, Inc. Development of Therapeutic Monoclonal Antibodies Against Her3 $ 135,139.00 $ 109,340.25
Escape Therapeutics, Inc. Development of an immune tolerant hESC source for allogeneic cell therapy applications $ 242,668.26 $ 1,810.98
Essentialis, Inc. Diazoxide Choline Controlled Release Tablets in the treatment of hypertriglyceridemia $ 244,479.24  
Eureka Therapeutics, Inc. MAGE 101: A Next-Generation anti-Her2 Antibody for Metastatic Breast Cancer Treatment $ 244,479.25  
EVOKE PHARMA, INC EVK-001 $ 244,479.25  
Excaliard Pharmaceuticals, Inc. Anti-Fibrosis Skin Scarring $ 244,479.24  
Existence Genetics, LLC Fully integrated and dynamic genetic testing, analysis, and reporting system $ 87,449.20 $ 157,030.05
Expression Drug Designs Biologic antagonism of S1P3 for the treatment of breast cancer $ 45,866.49 $ 54,844.39
EyeCyte, Inc. Drug-Mediated Cell Therapy For Diabetic Retinopathy $ 244,479.24  
Eye-Predict LLC Assessing brain disorders based on natural gaze features $ 42,139.00 $ 202,340.25
Fabrus LLC Anti-Angiogenic DLL4 Antibody Therapy for Cancer $ 244,479.25  
Fallbrook Engineering Inc Advanced Cord Blood Collection System $ 108,145.50 $ 95,902.00
Fate Therapeutics, Inc Novel bone Regenerative Therapy to Improve Healing and Reduce Healthcare Costs $ 244,479.25  
Fate Therapeutics, Inc Novel Regenerative Therapeutic to Restore Pancreatic Function to Cure Diabetes   $ 244,479.25
Fate Therapeutics, Inc. Patient-matched Cell Therapy to Cure Parkinson's Disease $ 244,479.25  
Fate Therapeutics, Inc. Novel therapy Targeting Cancer Stem Cells to Treat Highly Aggressive Cancers $ 244,479.25  
Fate Therapeutics, Inc. FT1050 to Improve Hematopoietic Stem Cell Transplants to Cure Leukemia/Lymphoma $ 244,479.25  
FEMTA PHARMACEUTICALS, INC FM101:Anti human IL-6 Monoclonal Antibody $ 244,479.24  
Ferrokin BioSciences, Inc. FBS0701:A novel iron chelator for the treatment of iron overload $ 244,479.25  
FFA Sciences LLC Diagnosing Acute Coronary Syndromes $ 44,864.50 $ 158,370.50
Fibrogen Inc FG-65155 for treatment of ischemia reperfusion injury post-myocardial infarction $ 244,479.25  
FIBROGEN INC Development of FG-3019 for treatment of locally advanced and metastatic pancreatic cancer $ 244,479.25  
Fibrogen Inc. FG-6874 Development for the Treatment of Oncologic Anemias $ 244,479.25  
FIBROGEN INC. FG-4592 Development for the treatment of Anemia of Chronic Kidney Disease $ 244,479.25  
Five Prime Therapeutics Inc FP-1039 (FGFR1c:Fc), a Novel Anti-Cancer Agent Acting as an Antagonist of Multiple Fibroblast Growth Factor Ligands, for the Treatment of patients of with Advance CancerMalignancies. $ 244,479.24  
Five Prime Therapeutics, Inc FP-1069 (CSF1Rc), a Novel Antagonist of CSC-1 and IL-34  for the Treatment of patients  with Inflammatory Disease and  Cancer. $ 244,479.24  
Flex Partners, Inc Micro Fluidics Therapeutic Delivery Pump $ 65,559.00 $ 178,920.24
Flow Pharma Inc. Microencapsulation for Next Generation HIV Vaccine $ 244,479.25  
Flow Pharma, Inc. Implantable, Microencapsulated Antibiotic $ 244,479.25  
Fluidigm Corporation Non-invasive prenatal diagnostic development $ 244,479.25  
Fluigence, LLC Development of a Handheld Bilirubin Bionsensor for Rapid Diagnosis of Neonatal Jaundice $ 21,897.00 $ 23,758.50
Fluxion Biosciences, Inc. The IsoFlux cancer diagnostic system $ 244,479.25  
ForSight VISION4, Inc Rechargeable drug delivery device for treatment of ocular disease $ 244,479.25  
FP Technology OCT-Based Non-Invasive Glucose Monitor $ 137,617.50 $ 106,861.75
FQUBED Inc fqubed's Development Project of NRI-1013 as a topical ibuprofen gel $ 90,155.16 $ 132,480.47
FQUBED Inc NRI-1018: Topical Etoricoxib for Treatment of Osteoarthitis $ 139,127.99 $ 105,351.26
FQUBED, Inc NRI-ANA:  Topical Lidocaine for the Treatment of Acute Herpes Zoster $ 63,888.97 $ 133,330.84
FQUBED, Inc NuPro and OxoFoam for Improved Treatment of Chronic Wounds $ 89,938.86 $ 97,309.69
FQUBED, Inc. Effective Topical Treatment of Nail Fungal Infection $ 110,959.88 $ 109,943.72
FQUBED, Inc. Topical Diclofenac for Relief of Osteoarthritis $ 244,479.25  
FREEDOM MEDITECH INC NON-INVASIVE OPHTHALMIC GLUCOSE MONITORING DEVICE $ 53,896.16 $ 74,430.37
Freedom Meditech Inc Non-Invasive Ophthalmic Diabetes Screening Device. $ 31,180.54 $ 74,031.12
FZIOMED, INC. OXIPLEX SPINE GEL $ 244,479.24  
Galaxy Biotech, LLC Humanized monoclonal antibody to FGF receptor 2 for treatment of gastric and other cancers $ 78,034.50 $ 55,497.50
Galaxy Biotech, LLC Humanized monoclonal antibody to Sonic Hedgehog protein (SHH) for treatment of cancer $ 106,162.50 $ 95,657.50
Galaxy Biotech, LLC Humanized monoclonal antibody to FGF2  for treatment of hepatoma and other cancers $ 61,817.50 $ 40,705.50
Galaxy Biotech, LLC Humanized monoclonal antibody to Wnt co-receptor LRP6 for treatment of cancer $ 13,123.50 $ 92,915.00
Gamma Medica -Ideas (USA) Inc SPECT-MRI Hybirid Molecular Imaging $ 84,754.00 $ 158,494.00
Gamma Medica-Ideas (USA) Inc Molecular Breast Imaging $ 244,479.25  
Gamma Medica-Ideas (USA), Inc. Translational Molecular Imaging $ 244,479.25  
GangaGen Inc. Prevention and Treatment of Staphylococcus aureus (MRSA) infection $ 244,479.24  
Gemmus Pharma Inc Novel treatment for influenza infections $ 20,508.50 $ 141,689.50
Genalyte Inc Silicon photonic sensor system for highly multiplexed diagnosis of multiple diseases $ 244,479.24  
GenapSys Inc Development of inexpensive, ultra-high throughput micro-electronic medical DNA sequencer.   $ 244,479.25
GENE SECURITY NETWORK INC ARRAY INFORMATICS TO UNDERSTAND PLOIDY CONCORDANCE $ 196,010.00 $ 48,469.25
Gene Therapy Systems Inc Creation & testing of a novel gene targeting vector for gene therapy $ 84,060.99 $ 84,643.75
Gene Therapy Systems Inc apid serodiagnostic test for active tuberculosis $ 46,072.63 $ 45,612.74
Genefluidics Inc Rapid phenotypic antibiotic susceptibility testing for evidence-based treatment for infection diseases. $ 244,479.25  
Genelux Corporation GL-ONC1 $ 244,479.24  
Geron Corporation GRNIC1: hESC-derived pancreatic islet cells for the treatment of diabetes $ 244,479.24  
Geron Corporation GRNCM1: Human Embryonic Stem Cell-Derived Cardiomyocytes for Heart Disease $ 244,479.24  
Geron Corporation GRNOPC1: hESC-derived oligodendrocyte progenitors for SCI & neurodegenerative disease $ 244,479.24  
Geron Corporation GRNVAC1, autologous therapeutic cancer vaccine $ 244,479.24  
Geron Corporation Imetelstat (GRN163L) $ 244,479.24  
GigaGen Inc. Personalized Companion Diagnostics for Myelodysplastic Syndrome $ 7,500.00 $ 236,979.25
Glaukos Corporation The iStent® Trabecular Micro-Bypass Stent $ 244,479.24  
Glumetrics, Inc. GluCath Intravascular Continuous Glucose Monitoring System $ 244,479.24  
GlySens Inc Implantable Glucose Monitor for Therapeutic Furtherance $ 244,479.25  
GT LIFE SCIENCES, INC. SYSTEMS BIOLOGY BASED BIOTHERAPEUTIC PRODUCTION $ 244,479.25  
Guided Delivery Systems, Inc Subcutaneous Mitral Valve Repair $ 244,479.25  
HALCYON Molecular Inc High-throughput single-molcule quantitative transcriptional profiling by EM $ 244,479.25  
Halcyon Molecular, Inc DNA sequencing using electron microscopy $ 244,479.25  
Halozyme, Inc. & Subsidiary Recombinant human hyaluronidase (rHuPH20) for subcutaneous drug delivery $ 244,479.25  
Halozyme, Inc. & Subsidiary Recombinant Human Cathepsin L for the treatment of collegan deposition disorders $ 244,479.25  
Halozyme, Inc. and Subsidiary PEGPH20, a novel treatment for solid tumors such as pancreatic cancer $ 244,479.25  
Halozyme, Inc. and Subsidiary Insulin-PH20-Ultrafast insulin for superior glycemic control in the treatment of diabetes $ 244,479.25  
Hana Biosciences Inc MARQIBO Cancer Therapeutic $ 244,479.25  
HANA BIOSCIENCES INC. Alocrest Cancer Therapeutic $ 148,327.67 $ 67,373.84
HANA BIOSCIENCES INC. Menadione Topical Lotion $ 244,479.25  
Hansen Medical Inc VASCULAR CATHETER CONTROL SYSTEM $ 244,479.25  
Harbor BioSciences Inc Triolex $ 244,479.25  
Harbor BioSciences Inc Apoptone $ 244,479.25  
Harbor Medical Inc DBA Sprixx Sprizz hand hygiene system $ 68,547.18  
HEMO THERAPEUTICS AQUAPHERESIS $ 118,362.50  
HOTSPUR TECHNOLOGIES INC PTA-PLUS $ 239,697.11 $ 4,782.14
HOTSPUR TECHNOLOGIES, INC MACERATOR-ASPIRATOR   $ 244,479.25
Hotspur Technologies, Inc EMBO-PLUS $ 178,946.39 $ 65,532.86
Hotspur Technologies, Inc. PTA DUO $ 56,404.83 $ 155,193.88
HourGlass Technologies, Inc Transoral Restrictive Intra Gastric Mesh Incisionless Gastric Banding system for weight loss $ 244,479.25  
Hunter Laboratories Inc HunterHeart $ 199,634.00 $ 44,845.25
Hunter Laboratories Inc HPV OncoTect Cancer Detection Diagnostic $ 244,479.25  
Huya Bioscience International LLC Development of HBI-8000: A Novel HDAC Inhibitor for Treatment of Cancer $ 244,479.24  
HydraDx Inc Importance of HydraDx Dehydration Diagnostic For Diagnosis and Monitoring State of Hydration $ 244,479.25  
Hyperion Therapeutics, Inc. HPN-100 (GPB) in Urea Cycle Disorders and Hepatic Encephalopathy $ 244,479.25  
ICB International Inc Diagnosis and treatment of Alzheimer's disease (AD) $ 244,479.24  
Ichor Medical Systems Inc Novel Delivery Platform for DNA Vaccine Delivery in Skin $ 49,356.09 $ 100,233.07
Ichor Medical Systems, Inc A xenogeneic DNA Vaccine for Melanoma $ 53,672.80 $ 91,831.78
Ichor Medical Systems, Inc IND-Enabling Biodistribution and Integration GLP Assays for DNA Drugs $ 13,022.30 $ 42,151.33
Ichor Medical Systems, Inc DNA Drugs Delivered with Novel Intramuscular Electroporation Technology $ 117,452.35 $ 117,648.59
Ichor Medical Systems, Inc. Therapeutic HBV DNA Vaccine Delivered withIchor's TDS Electroporation Technology $ 106,663.02 $ 137,816.23
Icon Bioscience, Inc Versiome Ophthalmic Drug Delivery System $ 244,479.25  
Icon Bioscience, Inc. IBI-10090 for Intraocular Injection $ 187,126.84 $ 57,352.41
Icon Bioscience, Inc. IBI-20089 for Intravitreal Injection $ 244,479.25  
ID FISH Technologies, Inc. Fluorescent in site hybridization assay kits (FISH kits) $ 226,876.00 $ 17,603.25
Idolo Biotechnology LLC Idolo $ 35,000.00 $ 57,933.50
IGeneX, Inc Bartonella FISH Diagnostic $ 211,861.57 $ 32,617.68
Igenica, Inc Novel Therapeutic Monoclonal Antibodies for Cancer $ 244,479.25  
Igenica, Inc. Novel Monoclonal Antibody for Treating Acute Myelogenous Leukemia   $ 244,479.25
IGT LLC dba Eigen Apollo: Robotic Needle Guidance System   $ 244,479.24
IGT, LLC dba Eigen Artemis:3D Imaging Workstation $ 244,479.24  
Imaginab, Inc. Contract Manufacturing of an in vivo Molecular Diagnostic for Imaging Agent of Prostate Cancer $ 12,244.30 $ 232,234.95
Imaginab, Inc. Contract Manufacturing of an in vivo Molecular Diagnostic for Imaging Autoimmune Disease $ 111,251.62 $ 133,227.63
iMetrikus, Inc System for Health Monitoring in Populations $ 244,479.25  
ImmPORT Therapeutics Inc. dba Antigen Discovery Inc Novel non-invasive diagnostics for liver diseases $ 94,750.00 $ 149,729.25
ImmPORT Therapeutics, Inc (dba) Antigen Discovery, Inc Safe and efficacious vaccine against Chlymedia $ 244,479.25  
ImmPORT Therapeutics,Inc.(dba).Antigen Discovery. Inc. Accurate and robust serodiagnostic test for Lyme Disease $ 130,404.50 $ 114,074.75
ImmunGene Inc. Development for the treatment of non-Hodgkins's lymphoma patients with genetic resistance. $ 200,326.57 $ 44,152.68
ImmunoCellular Therapeutics Ltd Development of a Cancer Vaccine for Glioblastoma (Brain Cancer) $ 244,479.25  
ImmunoScience, Inc. Salivax $ 244,479.25  
IMTEC Biomedical Inc IMTEC VasConnect and VasPort System for Vascular Access $ 48,114.00 $ 115,540.00
Imthera Medical Inc THN Sleep Therapy for Obstructive Sleep Apnea (OSA) $ 244,479.24  
IncellDx, Inc. E6, E7 mRNA Cervical and Anal Cancer Diagnostic $ 39,857.50 $ 204,621.75
Incline Therapeutics, Inc. IT101   $ 244,479.25
InCode BioPharmaceutics, Inc. C3 Complement Depletor Project $ 229,735.50 $ 14,743.75
Ingenuity Systems Inc Drug Respositioning, Biomarker and Therapeutic Target Discovery Program $ 244,479.25  
Inhibrx, Inc Development of a therapeutic antibody for the treatment of vascularized tumors   $ 244,479.25
Innovative Cell Technologies, Inc. Developing Clinical Grade Cell Dissociation Reagent for Embryonic Stem Cell Manufacturing $ 6,250.00 $ 61,375.00
Innovative Micro Technology Inc Early cancer detection : A MEMS-based cell sorter for CTC enumeration and functional testing $ 244,479.25  
Insera Therapeutics, Inc. Novel clot-retrieval and clot-filtering device for Stroke treatment including intra-arterial thrombolsys $ 125,000.00 $ 119,479.25
InSite Medical Technologies, Inc. Epiphany Epidural Access System $ 136,117.00 $ 108,362.25
InSite Vision, Inc ISV-303 Ocular Anti-Inflammatory Therapeutic $ 244,479.25  
InSite Vision, Inc. ISV-502 Therapeutic for Blepharitis and Lid Margin Disease $ 244,479.25  
Inspiration Biopharmaceuticals, Inc Recombinant Factor IX for the treatment of Hemophilia B $ 244,479.25  
Inspiration Biopharmaceuticals, Inc. Recombinant Porcine Factor VIII (OBI-1) for the Treatment of Acquired Hemophilia   $ 244,479.25
Intarcia Therapeutics, Inc Continuous, Subcutaneous Delivery of an Incretin Mimetic to Treat Type 2 Diabetes $ 244,479.25  
IntegenX Inc Apollo 200 $ 244,479.25  
IntegenX Inc Apollo 396   $ 244,479.25
IntegenX Inc Apollo 324   $ 244,479.25
IntegenX, Inc Apollo 100 $ 244,479.25  
Integrated Endoscopy, Inc Single use HD Endoscope $ 21,783.33 $ 25,000.00
Integrated Medical Systems Inc Life Support for trauma and transport commercialization $ 71,707.00  
InteKrin Therapeutics Inc INT131 A Safe Insulin Sensitizer for Treatment of Type 2 Diabetes $ 244,479.25  
Intellikine, Inc. Development of INK1117 for treatment of hematologic malignancies $ 132,457.00 $ 112,022.25
Intellikine, Inc. Development of INK1117 for treatment of solid tumors $ 244,479.25  
Intellikine, Inc. Development of INK1117 for treatment of solid tumors and hematologic malignancies $ 244,479.25  
Intellikine, Inc. Development of INK1117 for treatment of rheumatoid arthritis $ 244,479.25  
Intermune Inc. PIRFENIDONE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS $ 244,479.25  
INTERMUNE, INC Danoprevir Development Program $ 244,479.25  
Intermune, Inc. Next Generation HCV Therapeutic Discovery Program $ 244,479.25  
International Stem Cell Corporation and Subsidiaries hPSC $ 244,479.25  
Intersect ENT, Inc SpiderRX $ 244,479.25  
Intersect ENT, Inc CrownRX $ 244,479.25  
Interventional Spine Inc Percudyn System ("PDS") $ 244,479.25  
Intradigm Corporation (Silence Therapeutics, plc) Silence Therapeutics:  Novel RNAi Therapeutics $ 244,479.24  
IntraOp Medical Corporation Mobetron IOERT and Etanidazole Radiation Sensitizing Drug $ 244,479.24  
Intrinsic LifeSciences, LLC Development of FDA-approved Hepcidin Diagnostic Devices for Clinical Medicine $ 75,420.73 $ 169,058.51
Intuity Medical, Inc. POGO™ $ 244,479.25  
Ion Torrent Systems, Inc. Development of Next Generation Sequencing Platform for Molecular Diagnostic Applications $ 244,479.25  
iPierian Inc New Drugs for Amyotrophic Lateral Sclerosis (ALS) Discovered using iPS Cells $ 236,827.00 $ 7,652.25
iPierian, Inc. New Drugs for Spinal Muscular Atrophy Discovered using Induced Pluripotent Stem Cells $ 244,479.25  
IR2DX Inc Physician Office Metabolic Assessment   $ 37,500.00
IR2Dx, Inc Laboratory Panel - Metabolic and Atherosclerlerosis Assessment   $ 111,500.00
iRhythm Technologies Inc. The Zio [tm] Patch and ZEUS Project. $ 244,479.24  
IRIDEX Corporation Premixed, Sterile Single Dose Gas (Eye Gas) for Treatment of Retinal Detachments   $ 58,853.87
Iris BioTechnologies, Inc. Optimizing Personalized and Targeted Medical Treatment Using $ 34,808.50 $ 209,670.75
iScience Interventional iScience Microcatheter, for treatment of Macular Edema $ 244,479.25  
iScience Interventional iSceince Canaloplasty Project $ 244,479.25  
Islet Sheet Medical LLC Novel Islet Sheets Method for Treating Diabetes $ 53,746.57 $ 148,946.96
Itero Biopharmaceuticals Inc A newly formulated and differentiated recombinant follicle stimulating hormone, or rFSH. $ 244,479.25  
Itherx Pharmaceuticals Development of Novel Entry Inhibitors for Hepatitis C $ 244,479.25  
IVANTIS INC. Hydrus Aqueous Implant $ 244,479.25  
Jaden BioScience Inc AKA Jade BioScience inc Ultrasensitive cell surface detection of B-cell chronic lymphocytic leukemia(B-CLL) $ 26,089.00 $ 57,115.50
Jan Medical Inc. Jan Medical DCX Project $ 228,658.50 $ 15,820.74
Jazz Pharmaceuticals, Inc. JZP-6 Sodium Oxybate for the Treatment of Fibromyalgia $ 244,479.25  
Jazz Pharmaceuticals, Inc. PLE-1 Twice-Nightly Immediate Release Solid Oral Dosage Form of Sodium Oxybate $ 203,019.50 $ 41,459.75
Jazz Pharmaceuticals, Inc. JZP-8 Intranasal Clonazepam for the Treatment of Acute Repetitive Seizures $ 218,133.00 $ 26,346.25
Jazz Pharmaceuticals, Inc. PLE-2 Once-Nightly Controlled-Release Solid Oral Dosage Form of Sodium Oxybate $ 147,883.00 $ 96,596.25
Jennerex Inc Intravenous Treatment of Advanced Metastic Colorectal Cancer with JX-594 $ 244,479.24  
Jennerex Inc. JX-2011: A Novel Product for Advanced Metastatic Prostate Cancer $ 244,479.25  
Jennerex, Inc JX-594: A Novel Therapeutic for Direct Injection into Liver Tumor $ 244,479.25  
JN Biosciences, LLC Development of an immunosuppressive therapeutic antibody $ 109,300.00 $ 135,179.24
Juvaris Bio Therapeutics, Inc. Use of JVRS-100 to protect against ionizing radiation $ 244,479.25  
Juvaris BioTherapeutics Inc Use of JVRS-100 as an immunotherapeutic to treat Acute Myelogenous Leukemia $ 244,479.25  
Juvaris BioTherapeutics, Inc Combination of JVRS-100 with Francisella tularensis membrane fraction $ 244,479.25  
Juvaris BioTherapeutics, Inc. Use of JVRS-100 to protect against reperfusion injury $ 244,479.25  
KAI Pharmaceuticals, Inc KAI-1678 for Neurpathic Pain $ 244,479.25  
KAI Pharmaceuticals, Inc. KAI-9803 for Acute Myocardial Infarction $ 244,479.25  
KAI Pharmaceuticals, Inc. KAI-4169 for Secondary Hyperparathyroidism (SHPT) $ 244,479.25  
KaloBios Pharmaceuticals, Inc. Humaneered Monoclonal Antibody (KB003) for the Treatment of Rheumatoid Arthritis $ 244,479.24  
KaloBios Pharmaceuticals, Inc. Therapeutic Antibody (KB004) FOR THE Treatment of Hematological Malignancies $ 244,479.24  
KaloBios Pharmaceuticals, Inc. KB001-A for Treatment of Pseudomonas Aeruginosea in Cystic Fibrosis Patients $ 244,479.24  
KaloBios Pharmaceuticals, Inc. KB001- A for Treatment of Mechanically Ventilated Patients $ 244,479.24  
Kalos Therapeutics, Inc Kalos Therapeutics, Inc. Development of KT-220 $ 66,633.00 $ 177,846.25
Kalypsys, Inc. H4R Antagonist Project $ 244,479.25  
KenHealth LLC Percutaneous Closure Device   $ 244,479.25
KeraMed Inc New Artificial Cornea and Implantation Method for Treatment of Blindness $ 152,044.12  
Keren Parmaceutical, Inc. Development of External Guide Sequence (EGS) therapeutics for inflammatory lung disease $ 9,970.50 $ 12,612.50
KI Biotechnologies Automated Hight Throughput cRBC Stem Cell Hematopoietic Processing System   $ 244,479.24
KM Biotech, Inc. GM602 for treatment of Stroke and Parkinson's Disease indications $ 244,479.25  
Kona Medical Noninvasive Device Based Treatment for Hypertension   $ 244,479.25
Konan Medical USA, Inc Bionocular Analytic Dynamic Pupillometer   $ 115,000.00
Kythera Biopharmaceuticals Inc Nanoencapsulation of Therapeutic Proteins   $ 196,473.00
Kythera Biopharmaceuticals Inc ATX-101 $ 244,479.24  
Kythera Biopharmaceuticals, Inc ATX-104 $ 244,479.25  
Kythera Biopharmaceuticals, Inc ATX-202 $ 244,479.24  
LAAX, INC STROKE- LAAX PROJECT $ 244,479.25  
LakePharma, Inc Development of a Novel Recombinant Protein For The Treatment Of Diabetes And Cancer $ 40,850.00 $ 118,915.00
Lasmed Limited Liability Company Infrared diode-laser tools for pain diagnostics and management $ 117,426.24 $ 127,053.01
LENR Solutions, Inc. LENR LipoSector $ 76,631.00 $ 167,848.25
Lerner Medical Devices, Inc Targeted Phototherapeutic Treatment of Psoriasis at Home $ 244,479.25  
Leuchemix Inc CLINICAL STUDIES OF THE NOVEL ANTI-CANCER AGENT LC-1 $ 240,189.50 $ 4,289.74
Leukobyte, Inc. CytoPaint Extreme Analysis Software for Flow Cytometry $ 2,730.50 $ 241,748.75
Ligand Pharmaceuticals Inc Selective Androgen Receptor Modulators (SARM), LGD-4033 $ 244,479.25  
LIGAND PHARMACEUTICALS INC Thrombopoietin (TPO) LGD-4665 $ 244,479.25  
Ligand Pharmaceuticals Inc DARA $ 244,479.25  
LIGAND PHARMACEUTICALS INC Organon Collaboration $ 244,479.25  
Ligand Pharmaceuticals Inc Erythropoietin (EPO) Research Program $ 244,479.25  
Limerick BioPharma Inc LIM-075 ATP-binding cassette activator for safer immunosuppressant therapy in transplants $ 244,479.25  
Limerick BioPharma, Inc Limerick's Lipid Chaperones for treating metabolic disorders $ 244,479.25  
Livermore Instruments, Inc. BioAerosol Mass Spectrometry for Tuberculosis Diagnosis   $ 146,001.50
Loma Vista Medical, Inc Mulit-Layer Medical Balloons $ 244,479.24  
Lonestar Heart Inc Cardiogenic Stem Cell Modulators $ 244,479.25  
Lpath, Inc. Development of ASONEP™  for the treatment of Cancer $ 244,479.24  
Lpath, Inc. Development of iSONEP(TM) for the treatment of Age-related Macular Degeneration $ 244,479.24  
Lumen Therapeutics, LLC Nona-L-Arginine for Prevention of Saphenous Vein Graft Disease $ 53,472.49 $ 82,801.38
Luminous Medical Inc. Luminous Blod Glucose Monitor (LBGM) $ 244,479.25  
Lutran Industries Inc. DRH12 Acute Viral Nasopharyngitis   $ 244,479.25
Lutran Industries Inc. DRH12 Chronic Bronchitis   $ 244,479.25
Lutran Industries Inc. DRH12 Mother to Child Transmission of Gonorrhea   $ 244,479.25
Lutran Industries Inc. DRH12 Mother to Child Transmission of Chlamydia   $ 244,479.25
Lutran Industries Inc. DRH12 Mother to Child Transmission of Hepatitis   $ 244,479.25
Lutran Industries Inc. DRH12 Mother to Child Transmission of HPV   $ 244,479.25
Lypro Biosciences Inc Nano Disks $ 220,262.84 $ 24,216.40
MabPrex, Inc. Brain penetrating BMP-4 as a cancer stem cell differentiation therapy against glioblastoma $ 22,494.00 $ 221,985.24
Mabvax Threapeutics Inc Human Monoclonial Antibodies from Immunized patient Lymphocytes $ 244,479.24  
Mabvax Threapeutics, Inc Phase II Clinical Trial to determine efficacy of a vaccine to prevent recurrent sarcoma carbohydrate antigens in stage IV patients rendered disease free with the objective of preventing recurrent sarcoma $ 244,479.24  
Madera Biosciences, Inc. Small molecule angiogenesis inhibitors for cancer therapy $ 1,481.13 $ 8,500.00
MagArray, Inc Magnetic Nanoparticle Immunoassay System for Cancer Diagnostics $ 189,439.67 $ 55,039.57
Magellan Spine Technologies, Inc Magellan DART Technology $ 244,479.24  
Magnesensors, Inc Optimized magnetic nanoparticle labels for ultra-sensitive magnetic detection of pathogens   $ 48,995.00
Magnesensors, Inc Ultra-sensitive magnetic rare cell assays for leukemia $ 201,707.50 $ 42,771.75
Magnesensors, Inc Quantitive detection of nucleic acids without amplification for sepsis diagnostics $ 38,479.00  
Magnetecs Corporation Catheter guidance control & imging appartatus(CGCI) $ 244,479.25  
MandalMed, Inc. Galectin-3C for treatment of cancer and prevention of metastasis $ 30,264.00 $ 4,486.00
MAP Pharmaceuticals Inc LEVADEX ™ $ 244,479.25  
Mapp Biopharmaceutical Inc Vaginal Microbicide Antibodies $ 102,274.34 $ 9,063.39
Mapp Biopharmaceutical, Inc Biodefense Monoclonal Antibodies $ 244,479.25  
Mapp Biopharmaceutical, Inc Clostridium Difficile Monoclonal Antibodies $ 244,479.25  
Mapp Biopharmaceutical, Inc Alzheimer's Monoclonal Antibodies $ 151,031.76 $ 93,447.49
Mapp Biopharmaceutical, Inc. Respiratory Synctial Virus Antibodies $ 14,598.24  
Mariposa Biotechnology Inc Automated osmolaltiy control for cryogenic freezing or thawing $ 244,479.25  
Masimo Laboratories, Inc Improved Glucose Strip Reader   $ 244,479.25
Masimo Laboratories, Inc. Glucose 1 Non-Invasive Glucose Diagnostic Device $ 244,479.25  
Matrix Sensors, Inc. Matrix Sensors, Inc. $ 244,479.25  
Maven Technologies LLC LFIRE $ 197,015.00 $ 47,464.25
Maya Medical Inc Maya System   $ 244,479.25
Medbiocom Selective tumor vascular thrombogen $ 244,479.24  
Medbiocom Anti cancer prodrug activated by proteases of the coagulation cascade $ 244,479.25  
Medbiocom Cancer immune therapy targeting tumor associated macrophage $ 244,479.25  
Medical Tactile Inc SureTouch breast cancer detection and diagnostics $ 95,483.73 $ 148,995.51
MEDIVATION NEUROLOGY, INC Dimebon for the treatment of Huntington Disease $ 244,479.25  
MEDIVATION NEUROLOGY, INC Dimebon for the treatment of Alzheimer's Disease $ 244,479.25  
Medivation Prostate Therapeutics Inc MDV3100 for the treatment of advanced prostate cancer $ 244,479.25  
MedSolve Technologies, Inc Low Cost Micro Infusion Pump for the Treatment of Diabetes (Type 1 and Type 2) $ 35,412.50  
Mercator MedSystems, Inc. Catheter-directed renal sympathectomy to reduce hypertension $ 45,642.09 $ 198,837.16
MERITAGE PHARMA, INC ORAL VISCOUS BUDESONIDE $ 244,479.24  
Metabasis Therapeutics Inc Thyroid Receptor-beta Agonist $ 244,479.25  
METABASIS THERAPEUTICS INC Glucagon Receptor Agonist Program $ 244,479.25  
Metabolex Inc Development of MBX-3254 a GPR119 receptor agonist for the treatment of Type 2 Diabetes $ 185,654.00  
Metabolex Inc Development of MBX-2982 a GPR119 agonist for the treatment of Type 2 Diabetes $ 244,479.24  
Metabolex Inc Small molecule agonists of the bile acid receptor GPR131 for the treatment of type 2 diabetes $ 125,300.00 $ 119,179.24
Metabolex Inc Development of MBX-102 for the treatment of gout. $ 244,479.24  
Metabolex Inc Agonists of the anti-lipolytic receptor GPR81 for the treatment of Coronary Artery Disease $ 43,000.00  
Metabolex Inc Agonists of the fatty acid receptor GPR 120 for the treatment of type 2 diabetes $ 244,479.24  
Metabolex, Inc. Development of TRPM5 Activators for the treatment of Type 2 Diabetes   $ 229,396.00
Metabolex, Inc. MBX-8025 is a potential first-in-class therapy to treat mixed dyslipidemia $ 244,479.24  
Metronom Health, Inc. Continuous Glucose Monitoring System with Hypoglycemic Detection   $ 244,479.25
MiCardia Corporation MiCardia Encor Dynamic Heart Valve Repair Technology $ 244,479.24  
MicroCube LLC A Novel device("Wrist") for precise delivery of therapeutics/devices $ 147,000.00 $ 97,479.25
MicroCube LLC Novel Office-based Menorrhagia Treatment $ 244,479.25  
Micropoint Bioscience, Inc Developing POC In-Vitro Diagnostic Rapid Tests of Chronic and Acute Diseases $ 244,479.25  
MINDFRAME, INC Mindframe Interventional Recanalization is Ischemic Stroke (IRIIS) System $ 244,479.25  
Minerva Surgical, Inc Aurora System $ 244,479.25  
MingSight Pharmaceuticals MS-553, A Novel Oral Therapy For the Treatment of Diabetic Eye Diseases and Uveitis   $ 61,901.00
Minnow Medical Inc Peripheral Vascular System (PVS) $ 244,479.24  
Mitos Pharmaceuticals, Inc Use of Tempol to improve radiation treatments in head, neck, breast, and brain cancer. $ 244,479.24  
MLC Dx Inc DNA sequencing based recurrence test for Non-Hodgkin lymphoma $ 92,909.48 $ 151,569.77
Modulated Imaging Inc Advanced Medical Camera for Tissue Health Assessment $ 69,673.50 $ 154,201.00
Molecular GPS Technologies and Subsidiaries Molecular GPS Technologies' Influenza Vaccine 1230 Project $ 231,861.17 $ 12,618.08
Molecular GPS Technologies and Subsidiaries Molecular GPS Technologies' Aspergillus Program $ 170,310.90 $ 42,500.00
Molecular GPS Technologies and Subsidiaries Minisurf™ and Minisurf-R™ $ 136,453.51 $ 108,025.74
Molecular GPS Technologies and Subsidiaries Development Project of a New HSV2 Vaccine for Herpes genitalis (GH) $ 146,616.47 $ 97,862.78
Molecular Imaging and Therapeutics, Incorporated Development of single chain antibody conjugates against a unique prostate cancer antigen   $ 244,479.25
Molecular Response, LLC Tumor Anatomy Characterization - Developing a Validated Test for EGFRi Therapies   $ 244,479.25
Molecular Response,LLC Gene Expression Tests for Pedicting Lung Cancer Patient to EGFRi and HSP90i Therapy   $ 244,479.25
Mountain View Pharmaceuticals, Inc. PharmaPEG Technology for PEG-protein Drug Conjugates with Decreased Immunoreactivity $ 122,810.00 $ 121,669.25
Moximed, Inc Kinespring Knee implant system $ 244,479.25  
Mpex Phamaceuticals, Inc. AEROQUIN TM (MP-376: Levofloxacin Inhalation Solution) $ 244,479.25  
Multimeric Biotherapeutics, Inc. Precision immunization vaccine for nicotine and other drugs of abuse $ 3,518.68 $ 77,251.04
MyeloRx LLC Development of a triptolide derivative for acute myeloid leukemia and other cancers $ 32,748.00 $ 211,731.24
Mynosys Cellular Devices Inc Surgical Device For The Treatment Of Childhood Blindness Due to Lens Cataract $ 80,050.00 $ 164,429.24
NanoComposix, Inc Hollow Porous Silica Nanoparticles (HOPS Nanoparticles) $ 24,617.32 $ 82,257.18
NanoComposix, Inc. Gold Nanoparticle Matrices for MALDI-MS Diagnostic Applications $ 120,956.26 $ 101,819.19
NanoIVD, Inc Nanotechnology-based Cancer IVD Platform and Point-of-care Test $ 244,479.24  
NANOMIX, INC. Cardiac early detection biosensor $ 244,479.24  
NanoPacific Holdings, Inc Nanodevice Cancer Drug Delivery $ 244,479.25  
Nanostim Inc Nanostim's Leadless Cardiac Pacemaker $ 244,479.25  
NANOVASC INC NANOVASC DRUG-ELUTING VASCULAR GRAFT $ 244,479.24  
Napo Pharmaceuticals, Inc Development of crofelemer for treatment of secretory diarrhea $ 244,479.25  
Nativis Inc Digitax Therapeutic Treatment for Brain Cancer $ 244,479.25  
Nativis, Inc a-PCSK9s Therapeutic Treatment for Hypercholesterolemia $ 244,479.25  
Navigenics, Inc. Navigenics pharmacogenomics panel to predict medication response and risk of side effects $ 244,479.25  
NAVISCAN,INC POSITRON EMISSION MAMMOGRAPHY SCANNER FOR BREAST CANCER DIAGNOSIS $ 244,479.25  
Neodyne Biosciences, Inc Neodyne Device for Improved Healing and Scar Reduction $ 244,479.25  
NEOLAC, INC. PURIFIED SECRETORY IMMUNOGLOBIN TO PREVENT & TREAT NECROTIZING ENTERCOLITIS $ 11,350.09 $ 233,129.16
Neonc Technologies, Inc Development of Intranasal Delivery to the Brain $ 49,029.00 $ 195,450.25
Neostasis Inc T15 monoclonal antibody for the treatment of audioimmune disease. $ 244,479.25  
NeoSync Inc Neuro-EEG Synchronization Therapy $ 244,479.25  
NeoVista, Inc. CABERNET $ 244,479.24  
Nereus Pharmaceuticals, Inc Marizomib (NPI-0052 $ 244,479.25  
NEREUS PHARMACEUTICALS, INC. PLINABULIN $ 244,479.25  
Neugenesis Corporation Development of a Recombinant Influenza Virus-Like Particle Pandemic(H5N1)Vaccine $ 244,479.25  
NEUGENESIS CORPORATION Development of a cost effective polyclonal therapeutic against MRSA $ 55,398.00 $ 189,081.25
Neugenesis Corporation Develop Recombinant Virus-Like Particle Trivalent Seasonal Influenza Vaccine $ 244,479.25  
Neumedicines Inc NM-Gene Therapy $ 85,975.29 $ 43,947.23
Neumedicines, Inc HHS1: Characterization and Manufacturing Development of a Novel Anti-Tumor Therapeutic $ 23,414.67 $ 114,553.90
Neumedicines, Inc. HemaMax Advancement for Multiple Unmet Medical Needs in hematology/Oncology $ 244,479.24  
Neuralieve, Inc. Single pulse transcranial magnetic stimulation device for treatment/management of migraine. $ 244,479.25  
Neuraltus Pharmaceutical, Inc Neuraltus NP003 - Developing a treatment for Lysosomal Storage Disorders $ 176,543.50 $ 67,935.74
Neuraltus Pharmaceuticals,  Inc. Neuraltus NP001 - Developing a treatment for ALS and other neurodegenerative diseases $ 244,479.24  
Neuraltus Pharmaceuticals, Inc. Neuratus NP002 - A treatment for dyskinesias caused by l-dopa treatment of Parkinson's $ 244,479.24  
Neurocine Biosciences, Inc Development of GnRH antagonists (Elagolix) for endometriosis related pain $ 244,479.24  
Neurocrine Biosciences Inc Development of G protein-coupled receptor agonists or antagonists $ 244,479.24  
Neurocrine Biosciences, Inc. Development of Selective GPR119 Receptor Agonists for the Treatment of Type 2 Diabetes $ 244,479.24  
Neurocrine Biosciences, Inc. Development of VMAT 2 inhibitors for hyperkinetic movement disorders $ 244,479.24  
NEUROGEN CORPORATION Aplindore $ 244,479.25  
Neurogenetic Pharmaceuticals, Inc. Novel therapeutics for the prevention of Alzheimer's disease $ 169,963.00 $ 74,516.24
NeurogesX Inc Quetenza (capsaicin)8% patch $ 244,479.25  
NEUROGESX, INC NGX-1998-LIQUID HIGH CONCENTRATION TOPICAL CAPSAICIN $ 156,101.50 $ 88,377.75
NeurogesX, Inc. Acetaminophen Prodrugs $ 6,408.00 $ 137,913.00
NeuroPace,Inc. Responsive Neurostimulator Systems for Treating Neurological Diseases $ 244,479.25  
Nevro Corporation Senza SCS $ 244,479.25  
NewLife Sciences LLC, dba Scientific Imaginetics Final Phase Full-Scale US Launch of TMR Technology $ 244,479.25  
NEXMED PREVONCO FOR THE TREATMENT OF LIVER CANCER   $ 244,479.25
NEXMED Femprox for female sexual arousal disorder   $ 244,479.25
NEXMED Inc VITAROS FOR REYNAUD'S PHENOMENON   $ 244,479.25
NextWave Pharmaceuticals Inc Methylphenidate HCI Extended-Release Powder for Oral Suspension $ 244,479.25  
NextWave Pharmaceuticals Inc Mexocopm XR Tablet - clonidine extended release tablet $ 244,479.25  
NextWave Pharmaceuticals Inc Methylphenidate Extended Release Chewable Tablet $ 25,766.50 $ 218,712.75
NextWave Pharmaceuticals Inc Nexiclon XR Liquid - clonidine extended release liquid suspension $ 244,479.25  
NextWave Pharmaceuticals, Inc. Dexmethylphenidate Extended Release Formulation $ 57,486.00 $ 186,993.25
Nexus Dx Inc High Sensitivity cardiac panel $ 244,479.25  
Nexus Dx Inc Flu-ID $ 244,479.25  
NGM Biopharmaceuticals NPT1162 for Type 2 Diabetes Mellitus $ 244,479.25  
NGM Biopharmaceuticals, Inc. Disease Modifying Therapeutics for Type 2 Diabetes Mellitus $ 244,479.25  
NGM Biopharmaceuticals, Inc. Therapeutics to Enhance Compromised Muscle Function $ 244,479.25  
Nile Therapeutics, Inc CD-NP-Acute Heart Failure $ 244,479.24  
NOCIMED LLC NOCISCAN-MR Spectroscopy for Molecular Diagnosis of Discogenic Low Back Pain $ 233,732.16 $ 10,747.09
Nodality Inc Development of Molecular Diagnostics for Prediction of Treatment Response in AML $ 244,479.24  
Nodality Inc Molecular Diagnostics for Patient-Specific Characterization of Immune Dysfunction $ 74,491.00 $ 169,988.24
Nodality Inc Molecular Diagnostics for Drug Pathway Profiling in Hematologic Malignancies $ 244,479.24  
Nodality Inc Development of Molecule Diagnostics for Prediction of Treatment Response in MDS $ 244,479.24  
Nodality Inc Molecular Diagnostics for Prediction of Disease Progression and Treatment Response in CLL $ 244,479.24  
NovaBay Pharmaceuticals, Inc. Treatment of Impetigo $ 244,479.24  
NovaRx Corporation Pivotal phase III clinical trial of Lucanix for non-small cell lung cancer $ 244,479.24  
Novelix Pharmaceuticals, Inc. NVX-207 $ 16,741.00 $ 227,738.25
Novici Biotech, LLC Empirical Codon Optimization Technology for Biopharmaceutical & DNA Vaccine Improvement   $ 36,662.00
NovoMedix , LLC Treatment of Triple Negative Breast Cancer $ 5,060.50 $ 95,729.00
NovoMedix, LLC Treatment of Type II Diabetes $ 155,828.00 $ 26,264.50
NuCardia Inc HeartFlow $ 244,479.24  
NuMask, Inc. NuMask IntraOral Mask and Oropharyngeal Airway Research and Development $ 71,187.50  
NuMask, Inc. NuMask IntraOral Mask and Oropharyngeal Airway, Clinical Research   $ 142,829.50
Numedii using computational drug repositioning to develop novel lung cancer therapeutics $ 4,150.00 $ 240,329.25
Numerate Inc Novel drug products for treating latent and drug-resistant tuberculosis $ 170,689.46 $ 73,789.78
Numerate, Inc A novel drug for treating celiac sprue $ 159,084.28 $ 85,394.97
Numerate, Inc. A novel drug  for treating hepatitis C virus infections $ 189,658.15 $ 54,821.09
Nuon Therapeutics Inc NU3450 (tranilast) for the treatment of rheumatoid arthritis $ 244,479.25  
Nuon Therapeutics Inc. NU1618 for the treatment of chronic gout $ 244,479.25  
Nuveta, Inc IVF Technology $ 96,446.81 $ 21,883.50
Ocera Therapeutics Inc OCR-002 for Hyperammonemia & Resultant Hepatic Encephalopathy in Chronic Liver Disease $ 244,479.25  
Ocera Therapeutics Inc OCR-002 for Hyperammonemia & Resulant Hepatic Encephalopathy in Acute Liver Failure $ 244,479.25  
Ocera Therapeutics Inc AST-120 for the Treatment of Non-Constipating Irritable Bowel Syndrome (nc-IBS) $ 244,479.25  
Odyssey Thera, Inc miRNA Oncology Target Validation and Therapeutic Development $ 244,479.25  
Odyssey Thera, Inc. Development of Multi-Targeted Oncology Therapeurics $ 244,479.25  
Olema Pharmaceuticals, Inc. Oral Complete Anti-estrogens for the Treatment of Metastatic Breast cancer $ 144,092.60 $ 100,386.65
Oligasis, LLC A breakthrough technology for pharmaceuticals:  Validating and commercializing an enabling platform and manufacturing technology in collaboration with multiple pharmaceutical partners. $ 244,479.24  
Omniox, Inc. Overcoming Tumor Hypoxia with OMX-0004 to Revolutionize Chemo/Radiation Outcomes $ 230,794.86 $ 13,684.38
Omnueron Inc Therapeutic Technology for Real Time Functional MRI $ 244,479.25  
OMP, Inc Treatment for Melasma, NuDerm $ 244,479.25  
On Demand Therapeutics, Inc Laser activated, opthhalmic drug delivery implant for treating retinal diseases $ 244,479.25  
Oncolytics Biotech (U.S..) Inc. Reolysin $ 244,479.24  
OncoMed Pharmaceuticals Inc. OMP-21M18: Targeting DLL4 in Cancer Stem Cells for the treatment of cancer. $ 244,479.24  
OncoMed Pharmaceuticals, Inc OMP-59R5: Targeting Notch Receptors in Cancer Stem Cells for the treatment of Cancer $ 244,479.24  
OncoMed Pharmaceuticals, Inc Antibodies Targeting Notch Pathway Ligands for the Treatment of Cancer $ 244,479.24  
OncoMed Pharmaceuticals, Inc Inhibiting the Wnt Pathway for the Treatment of Cancer $ 244,479.24  
OncoMed Pharmaceuticals, Inc. OMP-18R5 Targeting the Wnt Pathway in Cancer Stem Cells for the Treatment of Cancer $ 244,479.24  
OncoTx Inc Isoforms of gene transcription proteins: Development of novel tools for cancer diagnosis $ 107,777.00 $ 136,702.25
Onset Medical Corporation Onset Controlled Deployment Technology $ 244,479.25  
Opal Therapeutics Inc Opal HIV - An Immunotherapy for HIV $ 11,469.50 $ 64,335.00
Open Monoclonal Technology Inc Monoclonal Antibody Cocktail Therapy $ 244,479.25  
Ophidion, Inc. Novel Cholinergic Therapeutics for Cognitive Enhancement $ 111,568.50 $ 97,650.00
Optimedica Corporation Image-guided femtosecond laser cataract surgery $ 244,479.25  
Optimer Pharmaceutical, nc. Fidaxomicin, a novel therapy for Clostridium difficile infections (CDI) $ 244,479.25  
OptiScan Biomedical Corporation Closed Loop Insulin delivery with an ICU Continuous Glucose Monitor $ 244,479.24  
Optovue Inc iVue $ 244,479.25  
OPTOVUE, Inc ACVUE $ 85,382.00 $ 159,097.25
Opus Pharmaceuticals, Inc L-FABP drugs as novel therapeutics for fatty liver disease, elevated lipids and obesity $ 49,880.50 $ 44,768.00
Oramic, LLC Electro-Fluidic Thrombolysis microcatherter for the clearing of vascular occlusions $ 20,138.50 $ 109,700.00
O-Ray Pharmaceuticals Sustained Release Inner Ear Delivery of Corticosteroid $ 22,500.00 $ 101,966.67
Orexigen Therapeutics, Inc Contrave $ 244,479.24  
Orexigen Therapeutics, Inc. Empatic $ 244,479.24  
Organovo Inc Biological 3D Bioprinted Blood Vessel $ 152,808.68  
Organovo Inc NovoGen 3D Bioprinter Development $ 184,735.50 $ 59,743.75
Orphagen Pharmaceuticals Novel Small Molecule Drug Class for the Treatment of Retinal Degeneration $ 88,752.50 $ 57,265.00
Orphagen Pharmaceuticals Novel Small Molecule Drug Class for the Treatment of Autoimmune Disease $ 176,533.50 $ 67,945.75
Orphagen Pharmaceuticals A novel drug class for treating adrenocortical cancer, prostate cancer and endometriosis. $ 29,494.00 $ 202,980.50
ORTHALIGN, INC. KneeAlign $ 244,479.25  
Osel, Inc. LACTIN-V-Preventing Recurrence of Female Urinary Tract Infections $ 162,466.00 $ 33,378.00
Osel, Inc. MucoCept-Development of a Novel Anti-HIV Microbicide $ 244,479.24  
Osseon Therapeutics, Inc. Osseoflex Balloon Tamp   $ 142,500.00
Otonomy, Inc OTO-203: Ciprofloxation + Dexamethasone Gel for Use During Tympanostomy Tube Surgery   $ 244,479.24
Otonomy, Inc. OTO-104: Sustained Release Dexamethasone Gel for Treatment of Meniere's Disease $ 244,479.24  
OvaGene Oncology Creation of a Cell Line System for Companion Diagnostic Development   $ 125,000.00
OvaGene Oncology Validation of STMN1 as a Predictor of Endometrial Cancer Recurrence   $ 147,500.00
OvaGene Oncology Molecular Definition of Atypical Endometrial Hyperplasia   $ 244,479.24
OXiGENE, Inc Development of CA4P as a Topical Treatment for Abnormal Vascular Ophthalmic Diseases $ 244,479.24  
OXiGENE, Inc Development of CA4P for the Treatment of Solid Tumor Cancers $ 244,479.24  
OXIGENE, Inc. Development of CA1P (OXi4503) for the Treatment of Solid Tumor and Hemotologic Cancers $ 244,479.24  
Pacira Pharmaceuticals Inc DepoNSAID - sustained release drug for improved treatment of pain and inflammation $ 35,796.71 $ 46,464.93
Pacira Pharmaceuticals, Inc EXPAREL™ -sustained release drug for postoperative pain relief and reduced opiod usage $ 244,479.25  
Pacira Pharmaceuticals, Inc. DepoMTX - sustained release drug for rheumatoid arthritis $ 124,187.58 $ 61,706.39
Pain Therapeutics PTI-721 $ 111,513.00 $ 132,966.24
Pain Therapeutics Inc PTI-421 $ 116,870.00 $ 127,609.24
Pain Therapeutics, Inc PTI-320 $ 244,479.24  
Pain Therapeutics, Inc Remoxy $ 244,479.24  
Pain Therapeutics, Inc Alzheimer's Treatment $ 11,745.00 $ 31,918.50
Pain Therapeutics, Inc. PTI-301 $ 244,479.24  
Pain Therapeutics, Inc. PTI-221 $ 117,643.00 $ 126,836.24
Pain Therapeutics, Inc. PTI-DX304 $ 38,630.00 $ 21,335.00
Pain Therapeutics, Inc. PTI-609 $ 244,479.24  
Pain Therapeutics, Inc. PTI-303 $ 244,479.24  
Panorama Research, Inc Inotropic Antibodies $ 40,293.65 $ 59,329.81
Panorama Research, Inc Novel Multiplex Assay for Biomarkers of Alzheimer's Disease $ 5,988.08 $ 72,399.00
Panorama Research, Inc Novel Therapy for Pemphigus Vulgaris by Treatment with a Cholinergic Agonist $ 7,193.96 $ 77,883.00
Panorama Research, Inc Novel TACE Inhibitors for Breast Cancer Therapy $ 61,536.98 $ 24,611.43
Panorama Research, Inc Novel Therapy for Diabetic Complications Using RAGE-Fc $ 168,624.62 $ 69,362.00
Panorama Research, Inc Kinetic Assembly of Bispecific Antibodies $ 76,103.69  
Panorama Research, Inc Myocardial Repair by Targeted Stem Cells $ 244,479.25  
Panorama Research, Inc Multiplex Biomarkers for Prostate Cancer $ 49,054.35 $ 38,586.50
Panorama Research, Inc. Anti-inflammatory Nicotinic Agonists for Therapy of Ulcerative Colitis $ 34,111.23 $ 147,003.00
Paracor Medical, Inc. HeartNet System $ 244,479.24  
Parallel Synthesis Technologies Inc Multiplex Serodiagnostic Test for Chagas Disease $ 244,479.25  
Pathologica, LLC Pathologica $ 244,479.25  
Pathwork Diagnostics, Inc Tissue of Origin Test $ 244,479.24  
Paul H Chen Corneal Epithelial Transplant Device-Jet Contact Lens $ 244,479.25  
Pavilion Medical Innovations LLC Pavilion Reversible Vena Cava Filter $ 64,964.50 $ 179,514.74
PaxVax Inc PaxVax - Cholera Vaccine $ 93,760.50 $ 150,718.75
PaxVax, Inc PaxVax - influenza vaccines $ 244,479.25  
PaxVax, Inc PaxVax - HIV Vaccine $ 83,323.00 $ 161,156.25
PaxVax, Inc. PaxVax - anthrax vaccine $ 244,479.25  
PEAK Surgical, Inc. PEAK Plasmablade Improving Patient Treatment Outcomes $ 244,479.25  
Pearl Therapeutics, Inc. PT003 - formoterol-glycopyrrolate combination HFA-MDI for COPD $ 244,479.25  
Pearl Therapeutics, Inc. PT001- glycopyrrolate HFA-MDI for treatment of COPD $ 244,479.25  
Pearl Therapeutics, Inc. PT010 - formoterol/glycopyrrolate/mometasone combination HFA-MDI for COPD $ 96,654.00 $ 147,825.25
PENUMBRA INC THE PENUMBRA EMBOLIZATION SYSTEM $ 244,479.25  
PENUMBRA, INC. THE PENUMBRA SYSTEM $ 244,479.25  
Peregrine Phamaceuticals Inc Bavituximab for the treatment of Refractory of Non-small Cell Lung Cancer $ 244,479.25  
Peregrine Pharmaceuticals Inc Bavituximab for the treatment of Non-Small Lung Cancer (Front-line Therapy) $ 244,479.25  
Peregrine Pharmaceuticals Inc Bavituximab for the treatment of patients Co-infected with HCV-HIV $ 238,783.50 $ 5,695.75
Peregrine Pharmaceuticals, Inc Cotara for the treatment of Glioblastoma Multiforme (GBM) $ 244,479.25  
Perseid Therapeutics LLC BA $ 96,183.50 $ 148,295.74
Perseid Therapeutics LLC PTLA $ 37,850.50 $ 206,628.74
Perseid Therapeutics LLC Maxy-4 $ 244,479.24  
Phage Pharmeceuticals Therapuetic treatment of chronic tympanic membrane perforation by fibroblast growth factor.   $ 244,479.25
PharmacoFore, Inc. Tamper-and-Abuse-Resistant Hydromorphone Prodrug $ 244,479.25  
PharmacoFore, Inc. PF0713: Safer IV Sedative-Hypnotic Agent $ 244,479.25  
PharmacoFore, Inc. PF03 MPAD: Multi-Pill Abuse-Deterrent (MPAD) Hydromorphone Prodrug $ 213,354.73 $ 31,124.52
Pharmaco-Kinesis Corporation Metronomic Biofeedback Pump (MBP) $ 244,479.25  
Pharmacyclics Inc Factor Vlla Inhibitor PCI-27483 $ 244,479.25  
Pharmacyclics Inc HDAC Inhibitor PCI-24781 $ 244,479.25  
Pharmacyclics, Inc. Btk Inhibitor PCI-32765 $ 244,479.25  
Pherin Pharmaceuticals, Inc. PH80 $ 102,708.25  
Pherin Pharmaceuticals, Inc. PH94B $ 131,068.25  
PHILOMETRON INC VENOUS STASIS ULCER THERAPY MANAGEMENT SYSTEM $ 68,413.00 $ 28,590.00
PhiloMetron, Inc Weight Management System $ 60,216.00 $ 106,989.00
PhiloMetron, Inc. Integrated Vascular Access stenosis Mitigation System $ 27,258.50 $ 74,813.50
Phoenix Biosystem Inc Rapid POC STD Molecular Diagnostics $ 143,760.00 $ 100,719.25
PhotoThera, Inc. NeuroThera Laser System and TLT for the Treatment of Acute Ischemic Stroke $ 244,479.25  
PIKAMAB Inc Development and Commercialization of ADCC Therasight™.   $ 244,479.25
PIKAMAB, Inc. Development and Commercialization of Lupus Therasight   $ 244,479.25
Piper Medical dba Odyssey Medical Technologies Portable, battery operated, low cost (<$500), Tactical CO2 Asthma and COPD Respiratory Therapy Device $ 22,262.00 $ 11,975.00
Piper Medical dba Odyssey Medical Technologies Quixie Cancer Drug Inhalation Therapy $ 8,415.50 $ 9,547.50
Planet Biotechnology Inc TEM-8Fc, An Anti-Cancer Immunoadhesin Made in Plants $ 13,948.50 $ 16,850.00
Planet Biotechnology Inc PBI-220 A Novel Therapy for Inhalational Anthrax $ 244,479.24  
Planet Biotechnology Inc PBI-230, a therapy for treatment of botulism $ 135,834.50 $ 108,644.74
PlenSat, Inc. Digestible Balloon Obesity Treatment $ 216,951.50 $ 27,527.74
Plexxikon Inc Small molecule inhibitors of CRAF kinase for the treatment of polycystic kidney disease $ 244,479.25  
Plexxikon Inc. Small molecule inhibitors of Fms receptor tyrosine kinase for the treatment of cancers $ 244,479.25  
Plexxikon Inc. Small molecule inhibitors of BRAF kinase for treatment of cancers $ 244,479.25  
PneumRx, Inc. RePneu ® Lung Volume Reduction Coil (LVRC) System $ 244,479.24  
Poincare Systems Inc AccuSwept MIS Surgical Device   $ 97,673.50
Portaero, Inc. Trans-Thoracic Wall Assisted Therapeutic Drug Administration for Emphysema $ 244,479.25  
Portola Pharmaceuticals Inc Elinogrel - Novel direct-acting competitive reversible P2Y12 inhilitor $ 244,479.25  
Portola Pharmaceuticals Inc PRT061103 $ 244,479.25  
Portola Pharmaceuticals, Inc PRT062607-Novel, oral Syk-specific inhibitor $ 244,479.25  
Portola Pharmaceuticals, Inc Betrixaban-Novel, oral, direct, Factor Xa inhibitor $ 244,479.25  
Portola Pharmaceuticals, Inc PRT062070 - Novel, oral Syk-Jak kinase inhibitor $ 36,720.50 $ 207,758.75
Portola Pharmaceuticals, Inc. PRT064445 - Universal Factor Xa Antidote $ 244,479.25  
Posit Science Corporation Plasticity-based Adaptive Cognitive Remedation (PACR) $ 244,479.25  
Praevium Research Inc Ultra-High Speed and Ultra-broadband Sources for Optical Coherence Tomography $ 148,096.50 $ 71,230.50
Precise Light Surgical Acute Ischemic Stroke treatment with localized tPA delivery $ 29,710.00 $ 214,769.25
Prediction Sciences LLC Theranostic for ischemic stroke $ 244,479.24  
PRESIDIO PHARMACEUTICALS, INC NS5B   $ 244,479.25
PRESIDIO PHARMACEUTICALS,INC NS5A $ 244,479.25  
Proacta HSMKI development program $ 244,479.24  
Proacta, Inc. PR104 development program $ 244,479.24  
Probactive Biotech, Inc Antibody targeted Liposomal Etoposide (provisionally referred as "ATLE") $ 242,539.52 $ 1,939.72
Probactive Biotech, Inc. Radioimmunotherapy (RIT) Iodine - 131 Antinuclear Antibody (ANA) $ 244,479.24  
Prodo Laboratories Inc. Human Islet Expansion $ 141,723.83 $ 102,755.42
Prodo Laboratories Inc. Human Islets For Research Resourcing & Distribution $ 134,137.63 $ 110,341.62
Progentech-USA, Inc. Progentech Integrated Molecular Diagnostic System $ 244,479.25  
Prognosys Biosciences Inc Technology for Mapping Protease Activity Across the Proteome $ 16,693.50 $ 68,236.50
Prognosys Biosciences, Inc. Technology for Multiplexed Profiling of Protease Activity   $ 103,875.50
Prognosys Biosciences, Inc. Technology for Mapping Protein Kinase Activity Across the Proteome   $ 66,428.50
Prolynx LLC Macromolecule-Drug Conjugate Delivery Platform $ 65,330.00 $ 179,149.24
ProSci Inc Novel HIV/AIDS Vaccine Project $ 244,479.25  
Prosetta Bioconformatics Inc BioConformatics $ 149,267.91 $ 95,211.34
Prosetta Bioconformatics, Inc Anti-Virals $ 244,479.25  
PROTELIX, INC. d/b/a PROTELICA A universal bioinformatics based Antibody Mimic Platform for the Discovery and Development of Novel Therapeutics $ 244,479.25  
Proteus Biomedical, Inc. Chipskin Technology $ 244,479.25  
Proteus Biomedical, Inc. The Raisin system $ 244,479.25  
Protigen Inc Development of Nephrilin for the treatment of diabetic complications and cancer $ 126,311.00 $ 118,168.24
Proveri Inc. Prostate Cancer Diagnostics and Prognostics $ 74,967.50 $ 169,511.74
Providence Medical Technology, Inc DTRAX Delivery System $ 244,479.24  
Psylin Neurosciences Inc Peptid Therapeutics for the treatment of Schizophrenia $ 244,479.25  
PSYLIN NEUROSCIENCES, INC. Peptide therapeutics for the treatment of depression $ 244,479.24  
PULMONX INC Chartis Pulmonary Assessment System and Zephyr Endobronchial Valve for Emphysema $ 244,479.25  
QLT Plug Delivery Inc Novel Punctal Plug Sustained Release Drug Delivery System - Opthalmics $ 244,479.24  
QUALIGEN INC ALPHA GST $ 31,531.00 $ 182,238.50
QuantaLife, Inc. Rapid low-cost MRSA diagnostics $ 244,479.25  
Quark Pharmaceuticals, Inc QPI-1007 for non-arteritic ischemic optic neuropathy (NAION) $ 244,479.24  
Quark Pharmaceuticals, Inc QPI-1002 (I5NP) for Delayed Graft Function (DGF) in Kidney Transplant $ 244,479.24  
Quark Pharmaceuticals, Inc. QPI-1002 (I5NP) for Acute Kidney Injury (AKI) $ 244,479.24  
Quexta, Inc Low inventory, low cost eyeglasses $ 80,950.50 $ 93,750.00
Quiescence Medical, Inc Pharyngeal Stent to Treat Sleep Apnea $ 53,200.00 $ 191,279.25
RadioRx, Inc RRx-001 $ 244,479.25  
Raptor Discoveries Inc WntTide, a peptide targeting LRP6 positive breast cancers $ 83,078.00 $ 137,450.00
Raptor Discoveries Inc. HepTide, a drug targeting peptide for the potential treatment of liver disease $ 111,027.00 $ 7,500.00
Raptor Therapeutics Inc DR Cysteamine for the potenial treatment of Huntington's Disease $ 220,167.50 $ 24,311.75
Raptor Therapeutics Inc DR Cysteamine for the potenial treatment of non-alocholic steatohepatitis (NASH) $ 215,299.50 $ 29,179.75
Raptor Therapeutics Inc DR Cysteamine for the potenial treatment of Cystinosis $ 244,479.25  
Receptos Inc Inhibition of lung inflammation associated with influenza viral infection $ 160,570.00 $ 83,909.25
Receptos Inc Small Molecule GLP1R Agonist Program $ 103,397.00 $ 141,082.25
Reduction Technologies Inc. Novel Therapy for the Non-Fusion Treatment of Adolescent Idiopathic Scoliosis $ 210,119.36 $ 34,359.89
Redwood Bioscience Inc Universal Carrier Scaffolds for Drug Delivery $ 58,352.96 $ 186,126.28
Regulus Therapeutics Inc Novel microRNA therapeutics for treatment of hepatitis C viral infection $ 244,479.25  
Regulus Therapeutics, Inc Novel microRNA therapeutics for treatment of fibrosis $ 244,479.25  
Relevare Pharmaceuticals Inc Combination therapy for the treatment of chronic neuropathic pain conditions $ 244,479.25  
Relia Diagnostic Systems, Inc Relia Diagnostic Systems, Inc $ 244,479.25  
Relypsa, Inc. RLY 106 polymer bile acid sequestrant ("BAS") for lowering cholesterol and glucose levels $ 244,479.24  
Relypsa, Inc. RLY 5016 Potassimum Management $ 244,479.24  
Renova Therapeutics, Inc Gene Therapy Transfer for Clinical Congestive Heart Failure $ 119,388.50 $ 125,090.75
Renovorx An Endovascular Catheter for Targeted Delivery of Drug/Cells to the Pancreas $ 6,250.00 $ 22,750.00
Replenish Inc Implantable Anterior MicroPump System for Glaucoma $ 244,479.25  
Replenish Inc Implantable Ophthalmic MicroPump for Retina Drug injections $ 244,479.25  
Resolution Biomedical Inc.  ClearPrep Cytology Solution and Test Kit $ 25,106.07 $ 219,373.18
Response Genetics Inc Genetic Profile Product Development $ 244,479.25  
Retina Pharma Inc To develop an Anti -Angiogenic Therapeutic for Wet Age related Macular Degeneration (AMD).   $ 244,479.25
RetroVirox, Inc Novel therapies for the treatment of HIV infection $ 35,914.69 $ 171,794.75
REVA Medical Inc Peripheral Biodegradabe Drug Delivery Stent   $ 244,479.25
REVA Medical, Inc REVA's Bioresorbable Drug-Eluting Stent $ 244,479.25  
REVA Medical, Inc. Structural Alloplastic Bone Graft (SABG) $ 127,415.50 $ 29,161.00
REVA Medical, Inc. Bioresorbable, Radiopaque Embolic Microspheres (BREMS) $ 60,250.00 $ 8,357.50
Revance Therapeutics, Inc. RT001 Topical Botulinum Toxin A for Plantar Fasciitis $ 244,479.25  
Revascular Therapeutics Inc Revascular Chronic Total Occulusion System $ 244,479.25  
Reverse Medical Corporation ACUTE STROKE INFUSION THROMBECTOMY CATHETER PROJECT $ 244,479.24  
ReVision Therapeutics Inc Development of Fenretinide for the Treatment of age-related macular Degeneration   $ 244,479.24
REVIVA PHARMACEUTICALS INC RP5000 PROGRAM FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS $ 146,982.00 $ 97,497.25
Ridge Diagnostics, Inc. Blood-based tests for the diagnosis and monitoring of Neuropsychiatric disorders $ 211,457.00 $ 33,022.24
Rigel Pharmaceuticals Inc Syk Inhibitors with Improved Specificity for the Treatment of Rheumatoid Arthritis $ 244,479.25  
Rigel Pharmaceuticals Inc Janus Kinase 2(JAK2) Inhibitor for the Treatment of Myeloproliferative Neoplasms $ 165,761.00 $ 65,927.00
Rigel Pharmaceuticals Inc PKC-theta inhibitors for the Treatment of Multiple Sclerosis $ 244,479.25  
RIGEL PHARMACEUTICALS INC Adiponectin Mimetics for the Treatment of Type 2 Diabetes $ 244,479.25  
Rigel Pharmaceuticals, Inc Spleen tyrosine kinase (Syk) Inhibitors for Treating Non-Hodgkins Lymphoma $ 244,479.25  
Rigel Pharmaceuticals, Inc JanUS Kinase 1/3 inhibitors for the Treatment and Prevention of Organ Transplant Rejection $ 244,479.25  
Rigel Pharmaceuticals, Inc. Inhibitors of Axl Kinase for the Treatment of Metastatic Disease $ 164,647.00 $ 8,356.50
Rigel Pharmaceuticals, Inc. Novel Treatments for Muscle Wasting $ 244,479.25  
Rigel Pharmaceuticals, Inc. Fostamatinib disodium (FosD), an oral syk inhibitor for treating Rheumatiod Arthritis (RA) $ 244,479.25  
Rigel Pharmaceuticals, Inc. Topical JAK 1/3 Inhibitors for the Treatment of Psoriasis $ 91,784.00 $ 152,695.25
Ritter Pharmaceuticals, Inc. RP-G28 A Novel Treatment of Lactose Intolerance $ 244,479.25  
Roxro Pharma, Inc SPRIX $ 244,479.24  
Ruga Corporation Targeted Cancer drug for Multiple Myeloma   $ 108,990.00
RUGA Corporation Cancer treatment targeting glucose metabolism   $ 244,479.25
Sadra Medical Inc. LotusTM Valve System for transcutaneous aortic valve replacement therapy $ 244,479.25  
SafeLife Corp Antimicrobial Catheters $ 194,891.50 $ 49,587.75
SafeLife Corp. Antimicrobial Respirator $ 244,479.25  
SanBio, Inc. SB623 Cell Therapy for the Recovery of Function from Disability Caused by Ischemic Stroke $ 244,479.25  
Sangamo BioScience, Inc. SB-313-xTZ for Recurrent or Refractory Glioblastoma Multiforme (GBM) $ 244,479.25  
Sangamo BioSciences, Inc SB-728-T for Human Immunodeficiency Virus/Acquired immunodeficiency Syndrome (HIV/AIDS) $ 244,479.25  
Sangamo BioSciences, Inc. SB-509 for Diabetic Peripheral Neuropathy(DPN) $ 244,479.25  
Sangamo BioSciences, Inc. SB-509 for Amyotrophic Lateral Sclerosis (ALS) $ 244,479.25  
Sanovas, Inc. Sanovas Interventional Drug Therapy $ 244,479.25  
SanRx Pharmaceuticals Inc Dipterinyl Calcium Pentahydrate (DCP) $ 14,847.50 $ 229,631.74
Sapheon Inc Sapheon Closure System $ 244,479.24  
SARCODE CORPORATION SARcode SAR  1118 Ophthalmic Solution $ 244,479.25  
Satiety, Inc TOGA $ 244,479.25  
Satiogen Pharmaceuticals Inc Colon/Rectum targeted GPBAR1 agonists for the treatment of obesity $ 51,039.00 $ 50,829.00
SATIOGEN PHARMACEUTICALS, INC AN ORAL, SMALL MOLECULE INHIBITOR OF THE ASBT FOR THE TREATMENT OF OBESITY $ 114,216.00 $ 71,488.00
SBIO Inc. SBIO SB1518 JAK2/FLK3 Inhibitor $ 244,479.24  
Scharp Technologies, Inc Burn and Wound Dressing Treatment   $ 244,479.25
SciClone Pharmaceuticals, Inc SciClone Oral Mucositis $ 244,479.25  
SciClone Pharmaceuticals, Inc SciClone Hepatitis C $ 244,479.25  
SciClone Pharmaceuticals, Inc. SciClone Vaccine Enhancer $ 221,306.50 $ 23,172.75
SciClone Pharmaceuticals, Inc. SciClone Oncology   $ 244,479.25
SCIGENE CORPORATION Automated genetic analysis system for human disease $ 216,842.50 $ 27,636.74
SCRIPPS LABORATORIES, INC. DIABETES - LOW COST HEMOGLOBIN A1C METER AND TEST $ 244,479.24  
SeaChange Pharmaceuticals, Inc Drug Repurposing using Chemoinformatic Links   $ 48,051.61
Sechrist Industries Inc Technological Advancements $ 172,045.00 $ 72,434.25
Sechrist Industries Inc Utility of Large Hyperbaric Chamber $ 203,864.00  
SEKRIS Corporation Pro-Apoptotic DNA Vaccination for the treatment of type 1 diabetes   $ 244,479.25
Selby Life Science LP Antiangiogenic Surrobodies ™ for the treatment of multiple cancers $ 208,891.58 $ 35,587.67
Selby Life Sciences LP Surrobodies [tm] for the treatment of Multiple Solid Tumor Cancers $ 219,832.84 $ 24,646.41
Selby Life Sciences, LP Surrobodies TM for the Treatment of Breast and Other Cancer $ 244,479.25  
Selby Life Sciences, LP Passive Immunity and Therapeutic Treatment of Seasonal Influenza $ 106,735.67 $ 137,743.58
Selby Life Sciences, LP Proapoptotic Surrobodies™ for the Treatment of Multiple Cancers $ 222,872.70 $ 21,606.54
Selby Life Sciences, LP Surrobodies ™ for the Treatment of Diabetes and Obesity $ 196,036.18 $ 48,443.07
Selexagen Therapeutics, Inc Hedgehog Pathway Inhibitor for the Treatment of Cancer $ 27,108.48 $ 217,370.77
Selexagen Therapeutics, Inc. Oncogenic BRAF Kinase (V600E)  Inhibitor for the treatment of cancer $ 2,087.29 $ 242,391.96
Senomyx, Inc. Sweet Enhancer Program $ 244,479.25  
Sensor Innovations, Incorporated (DBA Sensorin) Improved diabetes therapeutics administration via novel self-calibrating glucose sensor $ 244,479.24  
SentreHEART, Inc PLACE: Permanent Left Auricular Closure & Exclusion in Patients with Atrial Fibrillation $ 244,479.24  
Sequel Pharmaceuticals, Inc K201: a novel treatment for Atrial fibrillation $ 244,479.25  
Sequenom, Inc Age-related macular degeneration test   $ 244,479.25
SEQUENOM, INC. PRENATAL TESTING FOR TRISOMY 21 (DOWNSYNDROME) $ 244,479.25  
Sequent Medical Inc Woven EndoBridge Cerebral Aneurysm Embolization Device (WEB) $ 244,479.25  
Sialix Inc (formerly Gc-Free Inc) N-glycolyneuraminic Acid in the Pathogenesis and Progression of Rheumatoid Arthritis $ 6,376.00 $ 59,123.50
Sialix Inc (formerly Gc-Free Inc) Detection of Non-Human Sialic Acid in Biotherapeutic Applications $ 52,127.50 $ 42,714.50
Sialix, Inc (formerly Gc-Free,Inc.) Neu5Gc-Glycan Arrays for Discovery and Validation of Human Cancer Biomarkers $ 28,370.50 $ 86,694.50
Sierra Surgical Technologies Inc. Minimally Invasive System $ 244,479.24  
Silk Road Medical Inc FAST-CAS(Flow Altered Short Transcervical Carotid Artery Stenting) Research/Development $ 244,479.24  
Silver Lake Research Corporation Rapid Diagnostic Test Kit for Urinary Tract Infections $ 73,817.51 $ 145,222.90
Silver Lake Research Corporation Development of Rapid Diagnostic test Kit for Methicillin-Resistant Staph. Aureus   $ 53,665.12
Silver Lake Research Corporation EAP-Derived Monoclonal Antibodies for Cancer Diagnostics by Immunohistochemistry $ 23,802.44 $ 31,071.09
Silver Medical, Inc. Intra-operative monitoring of stroke in high-risk patient populations $ 10,868.50 $ 135,500.00
Solulink, Inc Highly multiplexed cancer biomarker assays. $ 41,622.00 $ 155,749.50
SomaGenics, Inc An RNA-based therapeutic for hepatitis C $ 244,479.25  
SomaGenics, Inc. miR-ID, a novel diagnostic platform for microRNAs and other small RNAs $ 76,535.82 $ 25,904.69
Somaxon Pharmaceuticals, Inc. Silenor (doxepin hydrochloride), a pharmaceutical treatment for insomnia $ 244,479.25  
Sonexa Therapeutics, Inc. ST101 Compound for Alzheimer's Disease $ 244,479.24  
Sorbent Therapeutics Inc CLP(Cross Linked Polyelectorlyte) $ 244,479.24  
Sorrento Therapeutics, Inc STI-MRSV   $ 150,000.00
Sorrento Therapeutics, Inc. STI-MRSA $ 195,089.50 $ 49,389.74
Sotera Wireless, Inc. ViSiMobile System $ 244,479.24  
Specialized Vascular Technologies, Inc EndoCoat Drug-Eluting Stent $ 244,479.24  
Spectral Molecular Imaging, Inc Early Melanoma Detection Device Using Hyperspectral Imaging $ 32,622.00 $ 157,550.00
SpectraScience Inc WavSTAT Optical Biopsy System-Inflammatory Bowel Disease-Cancer   $ 202,308.50
SpectraScience, Inc WavSTAT optical Biopsy System - Esophageal Cancer $ 244,479.24  
SpectraScience, Inc. LUMA Cervical Imaging System - FDA Post Approval Study $ 73,480.00 $ 41,731.00
SPECTROS CORPORATION NON-INVASIVE, TRANS-ABDOMINAL BROADBAND OXIMETER FOR EARLY-STAGE NEC DIAGNOSIS $ 79,006.00 $ 108,375.00
Spectros Corporation Real-Time Detection of Colon Ischemia During Abdominal Aortic Aneurysm Surgery $ 76,988.00 $ 55,908.50
Spectros Corporation ProstaFluor FDA Trail for Real-Time Margin Detection During Protatectomy $ 39,409.00 $ 205,070.24
Spectros Corporation Broadband Spectroscopic Localization of Breast Cancer $ 244,479.24  
Spectrum Pharmaceuticals Inc Renazorb $ 244,479.25  
Spectrum Pharmaceuticals Inc Zevalin $ 244,479.25  
Spectrum Pharmaceuticals, Inc. Apaziquone $ 244,479.25  
Spectrum Pharmaceuticals,Inc. Belinostat, a novel anti-cancer agent   $ 244,479.25
SpinalMotion, Inc Artificial Spinal Discs to Treat Back Pain More Effectively at Lower Cost that Spinal Fusion $ 244,479.24  
SpineAlign Medical Inc VerteLift $ 244,479.25  
Spiracur Inc SNaP $ 244,479.24  
Stategics, Inc Small molecule erythropoietin mimetics for the treatment of neurological disorders $ 28,629.82 $ 23,433.34
Stellar Biotechnologies, Inc Diagnostic Immune Status Monitoring in Patients with Immunodeficiency $ 244,479.24  
STELLAR BIOTECHNOLOGIES, INC. ENABLING ICH-S8 IMMUNOTOXICITY TESTING WITH KEYHOLE LIMPET HEMOCYANIN $ 244,479.25  
Stem CentRx, LLC Identification and Therapeutic of Solid Tumor Cancer Stem Cells $ 244,479.25  
StemCells California Inc HuCNS-SC Eye $ 244,479.25  
StemCells California, Inc. HuCNS-SC Spinal Cord Injury $ 244,479.25  
StemCells California, Inc. hLEC Project $ 244,479.25  
StemCells California, Inc. HuCNS-SC Brain $ 244,479.25  
Stemcyte Inc Chronic Spinal Cord Injury Treatment $ 244,479.25  
Stemcyte, Inc. Chronic Stroke $ 157,177.50 $ 87,301.75
Stemedica Cell Technologies, Inc. Allogenic Mesenchymal Stem Cell Therapy Stroke in the USA $ 244,479.25  
Stephen J Peroutka MD PhD Opioid Dose Reduction Taper Pack Device $ 4,805.00 $ 120,100.10
STKR, Inc. STKR QwikJect $ 143,516.50 $ 100,962.75
String Therapeutics Inc Creation of safe and effective PAP for development of immunotoxin for lupus   $ 175,000.00
String Therapeutics Inc Direct Intracranial administration of BMP-4 as Therapy Against Giloblastoma   $ 220,000.00
Stroma Medical Corporation Iris Stroma Retraction and Depigmentation $ 106,917.10 $ 137,562.15
Sunesis Pharmaceuticals, Inc Development of voreloxin for the treatment of patients with acute myeloid leukemia $ 244,479.24  
Suneva Medical, Inc. Artefill for the Treatment of HIV-Associated Lipoatropy $ 2,000.00 $ 242,479.25
SuperGen Inc SGI-1776-PIM Kinase Inhibitor (an anti-cancer compound) $ 244,479.25  
Sutro Biopharma, Inc Commercial Scale Cell-Free Production Enabling Novel Neutropenia Therapies $ 244,479.25  
SuviCa Inc. Lead optimization and biomarker identification for novel anti-cancer therapies   $ 102,500.00
Symor, Inc Symthetic TGF-beta ligands for bone repair and diseases   $ 244,479.24
Synedgen, Inc Novel Therapeutics to Treat Bacterial Infections including Drug Resistant Bacteria $ 218,735.00 $ 25,744.24
Synergenesis Inc MNC-1000 $ 20,964.71 $ 81,703.77
Synosia Therapeutics, Inc Clinical development of SYN115: a new chemical entity for treating Parkinson's Disease (PD) $ 244,479.25  
Synosia Therapeutics, Inc. Clinical development of SYN120: a new treatment for Alzheimer's disease (AD) $ 244,479.25  
Synthasome Inc Therapeutic Delivery for Tendon Repair $ 244,479.25  
T F Instruments Phase X-ray Diagnostic Imaging   $ 222,000.00
Tacere Therapeutics, Inc. Ocular (SMK-01/03)   $ 244,479.25
Tacere Therapeutics, Inc. Hepatitis C (TT-034) $ 244,479.25  
TaiMed Biologics USA Tamiphosphor for influenza infections $ 28,738.00 $ 54,213.50
TaiMed Biologics USA Ibalizumab for HIV-1 infections $ 244,479.24  
Talima Therapeutics, Inc Terbinafine Micro Implant (TMI-358) $ 244,479.25  
Tandem Diabetes Care Inc. T-Slim Infusion Pump - Diabetes $ 244,479.24  
Tandem Diagnostics, Inc Non-invasive prenatal diagnosis of fetal genetic abnormalities $ 111,484.38 $ 132,994.86
Taraxos, Inc. Novel Topical Analgesic for Peripheral Neuropathy $ 39,623.11 $ 57,500.00
Targeson Inc. Diagnostic Test for Crohn's Disease $ 112,793.00 $ 131,686.25
TARGETED MEDICAL PHARMA, INC Novel Treatment for Sleep Disorders in the Elderly $ 244,479.25  
TARGETED MEDICAL PHARMA, INC NEW THERAPY TO REDUCE SIDE EFFECTS OF PAIN DRUGS $ 244,479.25  
TARGETED MEDICAL PHARMA, INC. A safe and effective treatment for Gulf War illness $ 244,479.25  
Telik, Inc Phase 2 Randomized Clinical Trial of Telintra for Treatment of Severe Chronic Neutropenia. $ 208,368.00 $ 36,111.24
Telik, Inc Phase 2 Clinical trial of Telcyta for the treatment of Refractory Lymphoma & Multiple Myeloma $ 244,479.24  
Telik, Inc. Phase2 Clinical Trial of Telintra ® in Low to Intermediate-1 Risk Myelodysplastic Syndrome $ 244,479.24  
Telik, Inc. Clinical Trial of Telintra® & Revlimid® in Patients with Myelodysplastic Sydrome (MDS). $ 213,536.50 $ 30,942.74
Telik, Inc. Development of a Novel Inhibitor of Aurora and VEGFR Kinases for the Treatment of Cancer. $ 244,479.24  
Tethys Bioscience Inc Cardiovascular Event Prevention $ 244,479.25  
Tethys Bioscience, Inc. PreDx Diabetes Risk Score $ 244,479.25  
Tethys Bioscience, Inc. Diagnostics for the Prevention and Management of Cardiometabolic Disease   $ 142,933.00
TheraCell Inc. Stem Cell Separation and Gene Transfection Device' $ 137,527.00 $ 106,952.25
THERACOS INC THR-1442 $ 244,479.24  
Theracos, Inc THR-4450 $ 244,479.24  
Therapeutics Clinical Research, A Medical Corporation Carbazole $ 11,551.92 $ 175,760.76
Therapeutics Clinical Research, A Medical Corporation Super-Potent Corticosteroid Lotion $ 49,392.00 $ 195,087.25
Therapheresis, Inc TheraSystem I $ 130,545.00 $ 113,934.25
Theravance Inc A novel approach to the management of congestive heart failure $ 244,479.24  
Theravance Inc Improving the quality of life for patients with opioid-induced constipation $ 244,479.24  
Theravance Inc A novel approach to the management of uncontrolled hyper tension $ 244,479.24  
Theravance Inv Novel symptomatic and disease approach to the treatment of Alzheimer's Disease $ 244,479.24  
Theravance, Inc A novel treatment designed to cure Hepatitis C and prevent hepatocellular carcinoma $ 244,479.24  
Theravance, Inc Novel bifunctional muscarinic antagaonist-beta2 agonist for respiratory disorders $ 219,000.00 $ 25,479.24
Theravance, Inc A novel oral therapy for the treatment of pulmonary arterial hypertension $ 244,479.24  
Theravance, Inc A novel lung-selective muscarinic antagonist for chronic obstructive pulmonary disease $ 244,479.24  
Theravance, Inc A Novel analgesic optimized to reduce or replace opioid-based therapies for chronic pain $ 244,479.24  
Theravance, Inc. Novel approach to the treatment of resistant Gram-positive bacterial infections $ 244,479.24  
Theravance, Inc. Novel approaches for the tratment of Gram-negative bacterial infections $ 244,479.24  
THERAVIDA INC THVD-102 $ 244,479.25  
Theregen Inc. Clinical development of Anginera™ for the Treatment of Refractory Angina/Ischemia $ 244,479.25  
Therinject LLC Sustained Release Anti-Cancer Immuno-therapeutic Formulation Development $ 32,596.00 $ 7,664.00
Thermogenesis Corp. Res-Q 60 BMA $ 244,479.25  
TherOx, Inc. SSO2 Therapy for the Treatment of Heart Attack $ 244,479.24  
Threshold Pharmaceuticals Inc Hypoxia-Activated prodrug technology plaform for cancer drug discovery and development $ 244,479.25  
Threshold Pharmaceuticals, Inc. Clinical Development of Hypoxia Activated Prodrug TH-302 for the Treatment of Cancer $ 244,479.24  
Tioga Pharmaceuticals, Inc Asimadoline for the Treatment of Irritable Bowel Syndrome $ 244,479.24  
TLC Biopharmaceuticals, Inc. Lipotecan® TLC388 Anti-Tumor Therapeutic $ 241,979.50 $ 2,499.74
TM3 Therapeutics LLC A novel method of generating Therapeutic HIV vaccines $ 39,844.50 $ 204,634.75
TM3 Therapeutics LLC A respiratory prophylactic vaccine $ 29,883.50 $ 195,422.00
TM3 Therapeutics LLC A novel method of generating fully human monoclonal antibody therapeutics $ 29,883.50 $ 158,500.00
Tocagen Inc. Toca 511 with 5-FC to Significantly Improve Glioblastoma Multiforme Camcer Patient Survival $ 244,479.24  
Topica Pharmaceuticals, Inc Development of a Novel Antifungal, Luliconazole, for Onychomycosis $ 244,479.25  
Tosk, Inc TK-112690 for the Prevention of Cancer Chemotherapy Induced Mucositis $ 244,479.24  
Tosk, Inc. TK-115339 for the Prevention of Chemotherapy Induced Cardiotoxicity $ 95,220.35 $ 149,258.90
Tragara Pharmaceuticals Inc Capoxigem (apricoxib, TG01) an Oral COX-2 Inhibitor for the Treatment of Cancer $ 244,479.24  
Tragara Pharmaceuticals, Inc TG02, an Oral Multi-kinase Inhibitor for the Treatment of Cancer $ 244,479.24  
Transcend Medical Inc Drug-Eluting Microstent for Glaucoma Treatment $ 244,479.25  
Transcept Pharma, Inc INTERMEZZO $ 244,479.25  
Transdel Pharmaceuticals, Inc. Efficacy and Safety of Ketoprofen Cream in the Treatment of Acute Pain $ 244,479.25  
Transpose Medical LLC UGIB Therapy   $ 147,550.00
Transvivo, Inc. OMNI-OA $ 244,479.25  
Traversa Therapeutics, Inc Development of the PTD-DRBD delivery technology for siRNA drug therapies $ 244,479.25  
Traversa Therapeutics, Inc Development of RNA interference-based drug candidates for human brain cancer $ 243,868.00 $ 611.25
Trellis Bioscience, LLC Development of a human-derived antobody to prevent maternal-fetal transmission of CMV   $ 244,479.25
Trellis Bioscience, LLC Development of a human-derived antibody for pandemic influenza with broad strain efficacy   $ 244,479.25
TriAct Therapeutics, Inc. TT-100   $ 222,500.00
Trillium Engineering Inc Image-guided Liver Tumor Ablation using Internal Energy (Vapor) $ 34,517.50 $ 82,500.00
Trius Therapeutics, Inc. Torezolid research & Development $ 244,479.24  
TriVascular, Inc TriVascular's Ovation™ Abdominal Stent Graft System(Ovation ™ /ASGS) $ 244,479.25  
TriVascular, Inc. TriVascular's Thoracic Stent-Graft System $ 244,479.25  
Ultrawave Labs UltraWave Imaging Technology $ 62,747.49 $ 181,731.75
Universal Stabilization Technologies Inc Thermostable Rabies Vaccines for Oral Delivery $ 61,365.00 $ 131,694.00
Universal Stabilization Technologies Inc. Thermostable Measles Vaccines for Pulmonary Delivery $ 28,750.00  
US Biotest, Inc Progenitor Cell Engrafment $ 129,384.10 $ 115,095.14
US Biotest, Inc Treatment of Multiple-Cytopenias with TXA127 $ 244,479.24  
US Biotest, Inc Treatment of Acute Respiratory Distress Syndrome with TXA127.   $ 214,005.55
USGI Medical, Inc Development of Incisionless Operating Platform and procedure for the treatment of obesity $ 244,479.25  
Valent Technologies LLC VAL-083 $ 12,579.50 $ 231,899.74
Valentx, Inc ENDO BYPASS SYSTEM $ 244,479.25  
Vascular Biosciences CAR Peptide for Targeted Drug Delivery $ 66,876.00 $ 115,000.00
Vascular Designs, Inc. IsoFlow Ainfusion Catheter $ 158,850.50 $ 85,628.75
Vascular Imaging Corporation Intravascular ultrasound steerable imaging guidewire $ 244,479.24  
VasoNova, Inc. VasoNova-VPS $ 244,479.25  
Vaxart Inc Pediatric formulation for oral vaccines $ 38,704.50 $ 88,505.00
Vaxart Inc Vaccine for Venezeulan equine encephalitis $ 157,061.00 $ 87,418.25
Vaxart Inc Vaccine for Herpes Simplex Virus type 2 $ 16,366.00  
Vaxart Inc Vaccine to prevent pandemic avian influenza $ 92,701.50 $ 151,777.75
Vaxart Inc Oral-delivery vaccine for seasonal influenza $ 42,823.00 $ 41,095.00
Vaxiion Therapeutics, Inc. Commercialization of a novel, minicell-based, nano-sized targeted drug and RNAi delivery platform technology $ 117,783.00 $ 126,696.24
Velomedix Inc Novel Automated Peritoneal Lavage System for Controlled Induction of Therapeutic Hypothermia $ 244,479.25  
VentiRx Pharmaceuticals Inc TLR8 Agonist (VTX-2337): Targeted Novel Immunotherapy for Multiple Oncology Indications $ 244,479.24  
VentiRx Pharmaceuticals, Inc. TLR8 Agonist (VTX-1463): Novel Immunomodulatory Agent for Allergic Rhinitis and Asthma $ 244,479.24  
Veracyte, Inc Molecular profiling of thyroid nodules to determine benign or malignant cancer $ 244,479.25  
Veracyte, Inc. Lung Nodule Genomic Marker Panel Test $ 24,810.00 $ 122,442.00
Vermillion Inc A novel diagnostic test for the diagnosis of early stage ovarian cnacer (OVA2)   $ 244,479.25
Vermillion Inc A novel diagnostic test for the diagnosis of peripheral artery disease (PAD)   $ 244,479.25
Vertos Medical, Inc Vertos mild for Lumbar Spinal Stenosis $ 244,479.25  
VIA PHARMACEUTICLALS, Inc VIA-2291 $ 244,479.25  
ViaCyte, Inc Cell Therapy for Diabetes $ 244,479.25  
Vical Incorporated Allovectin-7 $ 244,479.24  
Vical Incorporated TransVax $ 244,479.24  
Virobay Inc Preclinical and Clinical Development of Cathepsin S inhibitor VBY-8911 $ 244,479.25  
VIROBAY, INC. Clinical Development of Cathepsin B Inhibirot VBY-376 for Liver Fibrosis $ 244,479.25  
Virogenics Inc A novel Immune Modulator/Adjuvant for HIV Vaccines $ 85,080.50 $ 16,544.50
Virogenics, Inc FIV Vectors for Treatment of Hemophilia A   $ 191,188.50
VisionCare Ophthalmic Technologies Inc IMT Project #002 $ 244,479.25  
Vital Therapies Inc ELAD Bioartificial Liver $ 244,479.24  
Vitalea Science Inc A finger-prick medical diagnostic for vitamin B12 malabsorption: An early intervention tool $ 219,682.44 $ 24,796.80
VITAPATH GENETICS, INC SPINA BIFIDA PREVENTION ASSAY $ 244,479.24  
VitaPath Genetics, Inc. Cleft Palate Prevention Assay $ 244,479.24  
VIVUS, INC. Qnexa $ 244,479.25  
VM Discovery, Inc Preclinical Development of VMD-902 for Chronic Neuropathic Pain $ 225,743.84 $ 18,735.40
Voyage Medical, Inc. Cardiac Ablation Under Direct Visualization $ 244,479.25  
Voyage Medical, Inc. Direct Visualization Cardiac Catheter for Transseptal Puncture and Drug Delivery IRIS ™ $ 244,479.25  
WaferGen Biosystems Inc. SmartChip Genetic Analysis for Molecular Identification of Disease States & Therapy Selection $ 244,479.25  
Wave 80 Biosciences, Inc. Molecular Diagnostic Assays and Instrumentation for HIV Viral Load Measurement $ 244,479.25  
Wintherix, LLC Wnt pathway inhibitor drug for epithelial and leukemic cancers $ 244,479.24  
Wiseman Research Initiatives LLC SV-BR-1-GM, a Whole-Cell Vaccine to Treat Various Types of Advanced Cancer $ 40,378.50 $ 20,189.50
XDX, Inc XDx Lupus Molecular Diagnostics $ 244,479.25  
XDX, Inc. XDx AlloMap: Molecular Diagnostic for Heart Transplant Acute Cellular Rejection $ 244,479.25  
Xencor Inc Development of biosuperior antibodies with extended half-life $ 244,479.25  
XENCOR INC Clinial development of XmAb5574 an antibody treating Chronic Lymphocytic Leukemia $ 244,479.25  
XENCOR, INC Clinical development of XmAb2513, a therapeutic antibody treating Hodgkin Lymphoma $ 244,479.25  
XENCOR, INC. Clinical development of XmAb5871, an antibody treating Lupus and other diseases $ 244,479.25  
XenoPort, Inc XP21279 - A Transported Prodrug of L-Dopa for the treatment of Parkinson's Disease $ 244,479.25  
XenoPort, Inc. Arbaclofen Placarbil, or AP - A Transported Prodrug of R-baclofen $ 244,479.25  
Xoft Inc Electronic brachytherapy for the treatment of Gynecological Cancers $ 244,479.25  
Xoft, Inc Electronic Brachytherapy for the Treatment of Breast Cancer $ 244,479.25  
XOMA Ltd XOMA Monoclonal Antibody Therapeutics for the Treatment of Oncologic Diseases $ 244,479.24  
Xoma Ltd XOMA's Heptavalent Anti-Botulinum Toxin Monoclonal Antibody Program $ 244,479.24  
XOMA Ltd XOMA Monocional Antibody Therapeutics for the Treatment of Metabolic Diseases $ 244,479.24  
Xoma Ltd XOMA 052, Gevokizumab, Anti-IL 1Beta, Anti-inflammatory therapeutic moncolonal anitbody $ 244,479.24  
Zacharon Pharmaceuticals, Inc Sensi-Pro Diagnosic for the Mucopolysaccharidoses ( MPS) $ 219,911.00 $ 24,568.24
Zacharon Pharmaceuticals, Inc Development of ZP2571: The first inhibitor of 6-O sulfation of herparan sulfate for cancer $ 244,479.24  
Zacharon Pharmaceuticals, Inc. Development of AP10295: A novel ganglioside inhibitor for the treatment of cancer $ 244,479.24  
Zacharon Pharmaceuticals, Inc. ZP2345: The First inhibitor of 2-O sulfation of heparan sulfate for the Mucopolysaccharidoses $ 181,546.50 $ 62,932.74
Zenobia Therapeutic, Inc Discovery of inhibitors of G2019S LRRK2 kinase for the treatment of Parkinson's disease $ 31,630.00  
Zenobia Therapeutics, Inc. Discovery of inhibitors of caspase 6 kinase for the treatment of Huntington's disease $ 12,500.00  
Zogenix Inc DosePro $ 244,479.25  
Zogenix, Inc. ZX002 $ 244,479.25  
ZOGENIX, INC. Sumavel DosePro $ 244,479.25  
Zosano Pharma, Inc. Novel PTH Microprojection System for improved treatment of severe osteoporosis $ 244,479.25  
ZYDX. Inc Prostate Cancer Multi-Analyte Diagnostic Test   $ 46,100.00
Zyomyx,Inc A novel CD4 point-of-care diagnostic test for HIV monitoring $ 244,479.24  

References/Related Topics

Page Last Reviewed or Updated: 05-Jun-2014